Aditxt, Inc.

EX-99.1 · PRESS RELEASE, DATED JUNE 9, 2026

EX-99.1
 6
 ea029430701ex99-1.htm
 PRESS RELEASE, DATED JUNE 9, 2026

 Exhibit 99.1

 Aditxt Signed Definitive Agreement Valuing
Ignite Proteomics at Approximately $150 Million

 Transaction values Ignite Proteomics at approximately
$150 million and is expected to position Ignite as an independent NYSE-listed functional proteomics company, while Aditxt continues as
a separate Nasdaq-listed company

 MOUNTAIN VIEW, CA, GOLDEN, CO and HONG KONG
— June 9, 2026 — Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”), a qualified acquisition corp and Ignite Proteomics,
LLC (“Ignite”, or “Ignite Proteomics”), a functional proteomics company and 100%-owned subsidiary of Aditxt, today
announced that Ignite and strategic counterparty agreed to sign a definitive business combination agreement.

 The transaction values Ignite at an implied equity
value of approximately $150 million , subject to the terms and conditions of the business combination agreement. Upon closing, Ignite
is expected to separate from Aditxt and become an independent publicly traded company through a newly formed public holding company expected
to be named Ignite Proteomics , Inc. (“Ignite Holdings, Inc,”, or “Pubco”) .

 Following closing, the acquisition corp. and Ignite
are expected to become wholly owned subsidiaries of the newly formed public holding company. Pubco’s common stock and public warrants
are expected to be listed on the New York Stock Exchange, subject to approval of the listing application and satisfaction of customary
closing conditions.

 For Aditxt, the transaction is expected to unlock
value in its 100%-owned Ignite subsidiary while allowing Aditxt to continue operating as a separate Nasdaq-listed public company, subject
to continued compliance with Nasdaq listing requirements.

 Strategic Value Creation for Aditxt

 Aditxt acquired Ignite as part of its strategy
to identify, acquire and advance differentiated health innovation platforms. The proposed business combination is intended to provide
Ignite with a dedicated public-company platform, greater visibility and access to growth capital, while highlighting the value of Ignite
within Aditxt’s portfolio.

 “Today’s announcement represents an
important milestone for Aditxt and Ignite,” said Jeff Busch, Interim Chief Executive Officer of Aditxt and Chief Executive Officer
of Ignite Proteomics . “Aditxt owns 100% of Ignite, a differentiated precision oncology asset, and this transaction is expected
to unlock that value through a business combination that values Ignite at approximately $150 million. At the same time, Aditxt is expected
to continue as a separate Nasdaq-listed company focused on advancing its broader health innovation strategy.”

 Mr. Busch continued, “For Ignite, becoming
an independent public company is expected to provide the focus, visibility and access to capital needed to accelerate commercialization,
expand clinical evidence generation and pursue broader adoption of its functional proteomics platform in oncology.”

 Advancing Functional Proteomics in Precision
Oncology

 Ignite is developing and commercializing a functional
proteomics platform designed to help physicians better understand the biological activity driving a patient’s tumor. Unlike traditional
approaches that may infer protein activity from genomic information, Ignite’s platform is designed to directly measure protein and
phosphoprotein signaling activity from tumor tissue, providing a functional view of tumor biology that may support more informed therapy
selection.

 Ignite’s current commercial focus is in
breast cancer, with a broader development strategy intended to support expansion into additional tumor types and treatment settings over
time. The company believes its platform may be particularly relevant as oncology treatment continues to shift toward increasingly targeted
therapeutic classes, including antibody-drug conjugates, immunotherapies and targeted therapies.

 Platform Positioned for Commercial and Clinical
Expansion

 Ignite’s growth strategy is expected to
focus on expanding clinical adoption, scaling commercial operations, supporting additional clinical evidence generation and pursuing collaborations
with academic institutions, oncology networks, payors and biopharmaceutical partners.

 Net proceeds from the transaction, including cash
remaining in the acquisition corp trust account after redemptions and any additional transaction financing, are expected to support Ignite’s
commercialization initiatives, clinical evidence generation, working capital needs and general corporate purposes.

 Transaction Overview

 The transaction is expected to result in Ignite
becoming an independent publicly listed company through a business combination with the acquisition corp. Following closing, the acquisition
corp. and Ignite are expected to become wholly owned subsidiaries of a newly formed public holding company.

 The transaction values Ignite at an implied equity
value of approximately $150 million , with Ignite equity holders expected to receive newly issued shares of Pubco common stock based
on a $10.00 per share reference price , subject to the terms and conditions of the business combination agreement.

 The boards of directors / managers of the applicable
parties have approved the transaction. Closing is subject to customary conditions, including approval by acquisition corp. shareholders,
approval by Ignite equity holders, effectiveness of a registration statement to be filed with the U.S. Securities and Exchange Commission,
approval for listing of Pubco’s common stock and public warrants on the NYSE, satisfaction of applicable regulatory and third-party
consent requirements, and satisfaction of minimum cash / financing conditions.

 Following closing, the combined company is expected
to be led by Ignite’s management team. Pubco’s board of directors is expected to consist of seven directors designated by
Ignite, including a majority of independent directors.

 2

 About Ignite Proteomics

 Ignite Proteomics is a functional proteomics company
focused on advancing precision oncology through direct measurement of protein expression and pathway activation. The company’s Reverse
Phase Protein Array platform is designed to measure functional protein and phosphoprotein activity from tumor tissue to support therapy-selection
insights across oncology.

 Ignite’s current commercial focus is in
breast cancer, with a broader development strategy intended to support future expansion into additional tumor types, therapeutic classes
and data-driven clinical applications.

 For more information, visit https://igniteproteomics.com/

 About Aditxt, Inc.

 Aditxt, Inc. (NASDAQ: ADTX) is a public company
focused on developing and commercializing health innovation platforms. Ignite Proteomics is currently a 100%-owned subsidiary of Aditxt.

 Through the proposed business combination, Aditxt
expects to unlock value in Ignite at an implied equity value of approximately $150 million , while Ignite is expected to become
an independent publicly traded company. Aditxt is expected to continue as a separate Nasdaq-listed public company, subject to continued
compliance with Nasdaq listing requirements.

 About the Acquisition Corp

 The undisclosed acquisition corp is a special
purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization
or similar business combination with one or more businesses.

 Advisors

 Ladenburg Thalmann & Co. Inc. is serving as
financial advisor to the newly formed public holding company and Ignite Proteomics, LLC, and Meister Seelig & Schuster PLLC is serving
as legal counsel.

 Additional Information and Where to Find It

 In connection with the proposed transaction, Pubco
intends to file with the SEC a registration statement on Form S-4, which will include a proxy statement / prospectus of the acquisition
corp. and Pubco. The acquisition corp., Pubco, Aditxt and Ignite urge investors, shareholders and other interested persons to read, when
available, the preliminary and definitive proxy statement / prospectus, as well as other documents filed with the SEC, because these documents
will contain important information about the acquisition corp., Pubco, Aditxt, Ignite and the proposed transaction.

 Investors and security holders will be able to
obtain free copies of the proxy statement / prospectus and other documents filed with the SEC by the acquisition corp, Pubco, Aditxt and
Ignite through the website maintained by the SEC at www.sec.gov .

 3

 Participants in the Solicitation

 The acquisition corp., Pubco, Aditxt, Ignite and
their respective directors, executive officers and other members of management and employees may be deemed to be participants in the solicitation
of proxies from the acquisition corp. shareholders in connection with the proposed transaction. Information regarding the persons who
may, under SEC rules, be deemed participants in the solicitation of the acquisition corps shareholders in connection with the proposed
transaction will be set forth in the registration statement / proxy statement / prospectus when filed with the SEC.

 No Offer or Solicitation

 This press release is for informational purposes
only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote, consent
or approval, in any jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of
applicable securities laws.

 Forward-Looking Statements

 This press release contains forward-looking statements
within the meaning of applicable federal securities laws, including statements regarding the proposed business combination, the anticipated
benefits of the transaction, the expected separation of Ignite from Aditxt, the expected listing of the combined company’s securities
on the NYSE, the implied equity value of Ignite, Aditxt’s expected continued Nasdaq listing, expected use of proceeds, Ignite’s
business strategy, clinical and commercial expansion plans, and the timing and ability of the parties to consummate the transaction.

 These forward-looking statements are subject to
risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements, including
risks related to the parties’ ability to satisfy closing conditions, obtain required shareholder and regulatory approvals, complete
any contemplated financing, satisfy NYSE and Nasdaq listing requirements, satisfy continued Nasdaq listing requirements applicable to
Aditxt, and execute their respective business and commercialization strategies. The parties undertake no obligation to update any forward-looking
statements, except as required by law.

 Media Contact:

 IR@aditxt.com

 4

EX-2.1 · BUSINESS COMBINATION AGREEMENT, DATED AS OF JUNE 10, 2026, BY AND AMONG COPLEY A

EX-2.1
 2
 ea029430701ex2-1.htm
 BUSINESS COMBINATION AGREEMENT, DATED AS OF JUNE 10, 2026, BY AND AMONG COPLEY ACQUISITION CORP., IGNITE PROTEOMICS HOLDINGS, INC., IGNITE MERGER SUB I INC., IGNITE MERGER SUB II LLC, IGNITE PROTEOMICS, LLC

 Exhibit 2.1

 BUSINESS COMBINATION AGREEMENT

 by and among

 Copley Acquisition Corp ,

 as SPAC,

 Ignite Proteomics Holdings, Inc.,

 as Pubco,

 Ignite Merger Sub I Inc.,

 as SPAC Merger Sub,

 Ignite Merger Sub II LLC ,

 as Company Merger Sub,

 Jeffrey M. Busch ,

 as Seller Representative,

 Chibo Tang ,

 as SPAC Representative

 and

 Ignite Proteomics, LLC ,

 as the Company

 Dated as of June 10, 2026

 TABLE OF CONTENTS

 Page

 I. MERGER
 3

 1.1. The SPAC
 Merger
 3

 1.2. The Company
 Merger
 3

 1.3. Effective Time
 3

 1.4. Effect of the Mergers
 3

 1.5. Governing Documents
 3

 1.6. Directors, Officers and Managers of the Surviving Subsidiaries
 4

 1.7. Conversion of SPAC
 4

 1.8. Merger Consideration
 4

 1.9. Effect of
 SPAC Merger on Issued Securities of SPAC and SPAC Merger Sub
 4

 1.10. Effect of Company Merger on Issued Securities of the Company and Company Merger Sub
 5

 1.11. Effect of
 Mergers on Issued and Outstanding Securities of Pubco
 6

 1.12. Sponsor
 Payment
 6

 1.13. Tax
 Consequences
 6

 1.14. Taking of
 Necessary Action; Further Action
 6

 II. CLOSING
 6

 2.1. Closing
 6

 III. representations and warranties of SPAC
 6

 3.1. Organization and Standing
 6

 3.2. Authorization; Binding Agreement
 7

 3.3. Governmental Approvals
 7

 3.4. Non-Contravention
 7

 3.5. Capitalization
 8

 3.6. SEC Filings and SPAC Financials
 9

 3.7. Absence of Certain Changes
 10

 3.8. Compliance with Laws
 10

 3.9. Actions; Orders; Permits
 10

 3.10. Taxes and Returns
 10

 3.11. Employees and Employee Benefit Plans
 11

 3.12. Properties
 11

 3.13. Material Contracts
 11

 3.14. Transactions with Affiliates
 11

 3.15. Investment Company Act
 11

 3.16. Finders and Brokers
 12

 3.17. Certain Business Practices
 12

 3.18. SPAC Trust Account
 12

 3.19. Exclusivity of Representations
 13

 3.20. Information Supplied
 13

 IV. representations and warranties of pubco AND THE MERGER SUBS
 13

 4.1. Organization and Standing
 13

 4.2. Authorization; Binding Agreement
 14

 4.3. Governmental Approvals
 14

 4.4. Non-Contravention
 14

 4.5. Capitalization
 15

 4.6. Ownership of Pubco Common Stock
 15

 i

 v. representations and warranties of THE COMPANY
 15

 5.1. Organization and Standing
 15

 5.2. Authorization; Binding Agreement
 16

 5.3. Capitalization
 16

 5.4. Subsidiaries
 17

 5.5. Governmental Approvals
 18

 5.6. Non-Contravention
 18

 5.7. Financial Statements
 18

 5.8. Absence of Certain Changes
 19

 5.9. Compliance with Laws
 19

 5.10. Company Permits
 19

 5.11. Litigation
 20

 5.12. Material Contracts
 20

 5.13. Intellectual Property
 22

 5.14. Taxes and Returns
 24

 5.15. Real Property
 25

 5.16. Personal Property
 25

 5.17. Title to and Sufficiency of Assets
 26

 5.18. Employee Matters
 26

 5.19. Benefit Plans
 27

 5.20. Environmental Matters
 30

 5.21. Transactions with Related Persons
 31

 5.22. Insurance
 31

 5.23. Top Customers and Suppliers
 31

 5.24 Certain Business Practices
 32

 5.25 Privacy and Data Security
 32

 5.26 Healthcare Compliance
 34

 5.27 Investment Company Act
 37

 5.28. Finders and Brokers
 37

 5.29. Exclusivity of Representations
 37

 5.30. Information Supplied
 37

 VI. COVENANTS
 38

 6.1. Access and Information
 38

 6.2. Conduct of Business of the Company
 39

 6.3. Conduct of Business of SPAC
 41

 6.4. Additional Financial Information
 44

 6.5. SPAC Public Filings
 44

 6.6. No Solicitation; Change in Recommendation
 44

 6.7. No Trading
 46

 6.8. Notification of Certain Matters
 47

 6.9. Efforts
 47

 6.10. Tax Matters
 49

 6.11. Further Assurances
 49

 6.12. The Registration Statement
 49

 6.13. Company Member Meeting
 51

 6.14. Public Announcements
 51

 6.15. Confidential Information
 52

 6.16. Documents and Information
 53

 6.17. Post-Closing Board of Directors and Executive Officers
 53

 6.18. Indemnification of Officers and Directors; Tail Insurance
 53

 6.19. Trust Account Proceeds
 54

 6.20. Transaction Financing
 55

 6.21. Qualification to do Business
 55

 ii

 VII. Closing conditions
 55

 7.1. Conditions of Each Party’s Obligations
 55

 7.2. Conditions to Obligations of the Company
 56

 7.3. Conditions to Obligations of SPAC
 58

 7.4. Frustration of Conditions
 59

 VIII. TERMINATION AND EXPENSES
 59

 8.1. Termination
 59

 8.2. Effect of Termination
 61

 8.3. Fees and Expenses
 61

 Ix. WAIVERS and releases
 62

 9.1. Waiver of Claims Against Trust
 62

 x. MISCELLANEOUS
 63

 10.1. Notices
 63

 10.2. Binding Effect; Assignment
 63

 10.3. Third Parties
 64

 10.4. Governing Law; Jurisdiction
 64

 10.5. WAIVER OF JURY TRIAL
 64

 10.6. Specific Performance
 64

 10.7. Severability
 64

 10.8. Amendment
 64

 10.9. Waiver
 65

 10.10. Entire Agreement
 65

 10.11. Interpretation
 65

 10.12. Counterparts
 66

 10.13. SPAC Representative
 66

 10.14. Counterparts
 67

 10.15. Legal Representation
 68

 XI DEFINITIONS
 69

 11.1. Certain Definitions
 69

 11.2. Section References
 82

 INDEX OF EXHIBITS

 Exhibit
 Description

 Exhibit A
 Seller Support Agreement

 Exhibit B
 Insider Letter Amendment

 iii

 BUSINESS COMBINATION AGREEMENT

 This Business Combination
Agreement (this “ Agreement ”) is made and entered into as of June 10, 2026 by and among (i) Copley Acquisition
Corp , a Cayman Islands exempted company (together with its successors, including after the Conversion in the State of Delaware (as
defined below), “ SPAC ”), (ii) Ignite Proteomics Holdings, Inc. , a Delaware corporation (“ Pubco ”),
(iii) Ignite Merger Sub I Inc. , a Delaware corporation and a wholly-owned subsidiary of Pubco (“ SPAC Merger Sub ”),
(iv) Ignite Merger Sub II LLC , a Delaware limited liability company and a wholly-owned subsidiary of Pubco (“ Company
Merger Sub ” and together with SPAC Merger Sub, the “ Merger Subs ”, and together with Pubco and
SPAC, the “ SPAC Parties ”), (v) Ignite Proteomics, LLC , a Delaware limited liability company (the “ Company ”),
(vi) Chibo Tang , solely in the capacity as the representative from and after the Effective Time (as defined herein) for SPAC shareholders
as of immediately prior to the Effective Time and their successors and assigns (other than the Sellers) in accordance with the terms and
conditions of this Agreement (the “ SPAC Representative ”), and (vii) Jeffrey M. Busch , solely in the capacity
as the representative from and after the Effective Time for the Sellers as of immediately prior to the Effective Time (and their successors
and assigns) in accordance with the terms and conditions of this Agreement (the “ Seller Representative ”). SPAC,
Pubco, SPAC Merger Sub, Company Merger Sub, Company, SPAC Representative and Seller Representative are sometimes referred to herein individually
as a “ Party ” and, collectively, as the “ Parties ”.

 RECITALS:

 A. The
Company is in the business of delivering pathway-level protein analytics to guide precision oncology (the “ Company Business ”);

 B. Pubco
is a newly incorporated Delaware corporation that is owned entirely by one or more managers or officers of the Sponsor, and Pubco owns
all of the issued and outstanding equity interests of SPAC Merger Sub and Company Merger Sub, each of which is a newly organized entity
formed for the sole purpose of effecting the Mergers (as defined below);

 C. Upon
the terms and subject to the conditions set forth herein, the Parties desire and intend to effect a business combination transaction pursuant
to which (i) SPAC Merger Sub will merge with and into SPAC, with SPAC continuing as the surviving entity (the “ SPAC Merger ”)
and as a result of which each issued and outstanding security of SPAC immediately prior to the effective time of the SPAC Merger shall
no longer be outstanding and shall automatically be cancelled in exchange for which the security holders of SPAC shall receive substantially
equivalent securities of Pubco and (ii) Company Merger Sub will merge with and into the Company, with the Company continuing as the surviving
entity (the “ Company Merger ”, and together with the SPAC Merger, the “ Mergers ”), and
as a result of which each issued and outstanding security of the Company immediately prior to the effective time of the Company Merger
shall no longer be outstanding and shall automatically be cancelled in exchange for which the security holders of the Company shall receive
shares of common stock of Pubco and (iii) as a result of which Mergers, SPAC and the Company will become wholly-owned subsidiaries of
Pubco and Pubco will become a publicly traded company;

 D. Prior
to the consummation of the Mergers, SPAC shall transfer by way of continuation out of the Cayman Islands and into the State of Delaware
so as to re-domicile as and become a Delaware corporation pursuant to the Companies Act (as Revised) of the Cayman Islands (as amended,
the “ Act ”) and the applicable provisions of the Delaware General Corporation Law (as amended, the “ DGCL ”);

 E. The
boards of directors of Pubco, SPAC and SPAC Merger Sub have each (i) determined that the respective Mergers to which they are a party
are fair, advisable and in the best interests of their respective companies and stockholders or shareholders (as relevant), (ii) approved
this Agreement and the transactions contemplated hereby, including, with respect to Pubco, the Conversion and the respective Mergers to
which they are a party, upon the terms and subject to the conditions set forth herein, and (iii) determined to recommend to their respective
stockholders, shareholders or class or stockholders or shareholders (as relevant) the approval and adoption of this Agreement and the
transactions contemplated hereby, including, with respect to Pubco, the Conversion and the respective Mergers to which they are a party
(in case of the recommendation of the board of directors of SPAC, the “ SPAC Board Recommendation ”);

 1

 F. The
board of managers (or manager or managing member(s), as applicable) of the Company has (i) determined that the Company Merger is fair,
advisable and in the best interests of the Company and its members, (ii) approved this Agreement and the transactions contemplated hereby,
including the Company Merger, upon the terms and subject to the conditions set forth herein, and (iii) determined to recommend to its
members the approval and adoption of this Agreement and the transactions contemplated hereby, including the Company Merger;

 G. Contemporaneously
with the execution and delivery of this Agreement, SPAC has received voting and support agreements in the form attached as Exhibit
A hereto (collectively, the “ Seller Support Agreements ”) signed by the Company and the Sellers with respect
to the Company Interests (as defined herein) held by them sufficient to approve the adoption of this Agreement and approve the Company
Merger and the other transactions contemplated by this Agreement;

 H. At
or prior to the Effective Date, the Sellers and the directors and officers of the Company shall have each entered into a Lock-Up Agreement
in form and substance reasonably satisfactory to SPAC and the Company (each, a “ Lock-Up Agreement ”);

 I. Contemporaneously
with the execution and delivery of this Agreement, SPAC, the Company, Pubco and the IPO Underwriter have entered into an amendment to
the Insider Letter Agreement with the Sponsor and SPAC’s directors and officers, a copy of which is attached as Exhibit B
hereto (the “ Insider Letter Amendment ”), pursuant to which, among other matters, effective as of the Closing,
(a) Pubco shall assume and be assigned the rights and obligations of SPAC under the Insider Letter and (b) revise the existing lock-up
restrictions, subject to and contingent upon the Closing;

 J. At
or prior to the Effective Date, SPAC, Pubco and the Company shall have entered into a Non-Competition and Non-Solicitation Agreement in
favor of Pubco and the Company with Jeffrey M. Busch, in form and substance reasonably satisfactory to SPAC and the Company (collectively,
the “ Non-Competition Agreements ”), which will be effective as of Closing and will provide for a restricted period
from the Closing until the third anniversary of the Closing Date;

 K. Contemporaneously
with the Closing, SPAC, Pubco, the Sponsor and the Sellers, will execute and deliver an amendment and restatement of the Founder Registration
Rights Agreement, in form and substance reasonably satisfactory to SPAC and the Company (the “ Amended Registration Rights
Agreement ”), to, among other matters, have Pubco assume the registration obligations of SPAC under the Founder Registration
Rights Agreement, have such rights apply to the shares Pubco Common Stock, and to provide Sellers with registration rights thereunder;

 L. Promptly
following the date hereof, Pubco intends to enter into employment agreements with SPAC and each of Jeffrey M. Busch, Faith Zaslavavsky
and Ronald Tam (collectively, the “ Employment Agreements ”), in each case to be effective as of Closing;

 M. The
Parties hereby agree and acknowledge that for U.S. federal income Tax purposes, the Mergers are intended to qualify as an exchange described
in Section 351 of the Code, and each of the Parties acknowledges and agrees that each is responsible for paying its own Taxes, including
any adverse Tax consequences that may result if the Mergers do not qualify under Section 351 of the Code (as defined herein); and

 N. Certain
capitalized terms used herein are defined in Article XI hereof.

 2

 NOW, THEREFORE , in
consideration of the premises set forth above, which are incorporated in this Agreement as if fully set forth below, and the representations,
warranties, covenants and agreements contained in this Agreement, and intending to be legally bound hereby, the Parties hereto agree as
follows:

 Article
I

MERGER

 1.1 The
SPAC Merger . At the Effective Time and subject to and upon the terms and conditions of this Agreement, and following the Conversion
(as described in Section 1.7 ), and in accordance with the applicable provisions of the DGCL, SPAC Merger Sub and SPAC shall consummate
the SPAC Merger, pursuant to which SPAC Merger Sub shall be merged with and into SPAC, following which the separate corporate existence
of SPAC Merger Sub shall cease and SPAC shall continue as the surviving corporation in the SPAC Merger. SPAC as the surviving corporation
after the SPAC Merger is hereinafter sometimes referred to as “ SPAC Surviving Subsidiary ” (provided, that references
to SPAC for periods after the Effective Time shall include SPAC Surviving Subsidiary).

 1.2 The
Company Merger . At the Effective Time and subject to and upon the terms and conditions of this Agreement and in accordance with the
applicable provisions of the Delaware Limited Liability Company Act (“ DLLCA ”), Company Merger Sub and the Company
shall consummate the Company Merger, pursuant to which Company Merger Sub shall be merged with and into the Company, following which the
separate limited liability company existence of Company Merger Sub shall cease and the Company shall continue as the surviving limited
liability company in the Company Merger. The Company as the surviving limited liability company after the Company Merger is hereinafter
sometimes referred to as “ Company Surviving Subsidiary ” (provided, that references to the Company for periods
after the Effective Time shall include Company Surviving Subsidiary), and together with SPAC Surviving Subsidiary, the “ Surviving
Subsidiaries ” (provided, that notwithstanding the Company Merger, the Company will not be included within the meaning of
the term SPAC Parties for purposes of this Agreement).

 1.3 Effective
Time . Subject to the conditions of this Agreement, and following the Conversion (as described in Section 1.7 ), the Parties
shall (i) cause the SPAC Merger to be consummated by filing a certificate of merger in form and substance reasonably acceptable to the
Company and SPAC (the “ SPAC Certificate of Merger ”) with the Secretary of State of the State of Delaware in
accordance with the applicable provisions of the DGCL, and (ii) cause the Company Merger to be consummated by filing a certificate of
merger in form and substance reasonably acceptable to the Company and SPAC (the “ Company Certificate of Merger ”)
with the Secretary of State of the State of Delaware in accordance with the applicable provisions of the DLLCA, with each of the Mergers
to be consummated and effective simultaneously at 5:00 p.m. New York City time on the Closing Date or at such other date and/or time as
may be agreed in writing by the Company and SPAC and specified in each of the SPAC Certificate of Merger and the Company Certificate of
Merger (the “ Effective Time ”).

 1.4 Effect
of the Mergers . At the Effective Time, the effect of the Mergers shall be as provided in this Agreement and the applicable provisions
of the DGCL, DLLCA and other applicable Law. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time
all the property, rights, agreements, privileges, powers and franchises of SPAC Merger Sub and Company Merger Sub shall vest in SPAC Surviving
Subsidiary and Company Surviving Subsidiary, respectively, and all debts, liabilities, obligations and duties of SPAC Merger Sub and Company
Merger Sub shall become the debts, liabilities, obligations and duties of SPAC Surviving Subsidiary and Company Surviving Subsidiary,
respectively, including in each case the rights and obligations of each such Party under this Agreement and the Ancillary Documents from
and after the Effective Time.

 1.5 Governing
Documents . At the Effective Time, (i) each of the certificate of incorporation and bylaws of SPAC Merger Sub shall become the certificate
of incorporation and bylaws of SPAC Surviving Subsidiary, respectively, (ii) the name of the SPAC Surviving Subsidiary shall be amended
to be such name as is determined by Pubco and (iii) each of the certificate of formation and operating agreement of Company Merger Sub
shall become the certificate of formation and operating agreement of Company Surviving Subsidiary, respectively, except that the name
of Company Surviving Subsidiary in such certificate of formation and operating agreement shall be as mutually agreed between SPAC and
the Company.

 3

 1.6 Directors,
Officers and Managers of the Surviving Subsidiaries . At the Effective Time, (i) the board of directors and executive officers of SPAC
Surviving Subsidiary shall be the same as the post-Closing board of directors and executive officers of Pubco, after giving effect to
 Section 6.17 , each to hold office in accordance with the organizational documents of SPAC Surviving Subsidiary until their successors
are duly elected or appointed and qualified or their earlier death, resignation, or removal, and (ii) the board of managers and executive
officers of Company Surviving Subsidiary shall be designated by the Company, each to hold office in accordance with the organizational
documents of the Company Surviving Subsidiary until their successors are duly elected or appointed and qualified or their earlier death,
resignation, or removal.

 1.7 Conversion
of SPAC . Prior to the Effective Time and prior to consummating the SPAC Merger, and subject to (i) obtaining the approval of the holders
of the SPAC Ordinary Shares in accordance with SPAC’s Organizational Documents, the Act and the DGCL and (ii) SPAC duly filing (1)
the Cayman Conversion Documents with the Cayman Islands Registrar of Companies (the “ Cayman Registrar ”) and
(2) the Delaware Conversion Documents with the State of Delaware, SPAC shall adopt Delaware Organizational Documents in a form satisfactory
to SPAC (the “ Conversion Organizational Documents ”) (with such changes as may be agreed in writing by SPAC and
the Company), SPAC shall transfer by way of continuation out of the Cayman Islands and into the State of Delaware so as to convert into
and become a Delaware corporation pursuant to the Act and the applicable provisions of the DGCL (the “ Conversion ”).
In connection with the Conversion, all of the issued and outstanding SPAC Securities shall remain outstanding and become substantially
identical securities of SPAC as a Delaware corporation (including the Class A Ordinary Shares and Class B Ordinary Shares becoming simple
common stock of SPAC as a Delaware corporation).

 1.8 Merger
Consideration . The aggregate consideration to be paid to holders of the Company Interests as of the Effective Time (collectively,
the “ Sellers ”) pursuant to the Company Merger shall consist of a number of newly issued shares of Pubco Common
Stock equal to One Hundred and Fifty Million U.S. Dollars ($150,000,000) divided by Ten U.S. Dollars ($10.00) (the “ Merger
Consideration ”). At the Effective Time, the Company Interests (excluding the Excluded Interests, if any), issued and outstanding
as of immediately prior to the Effective Time shall be automatically canceled and extinguished and converted into the right for the respective
Sellers to receive their respective Percentage Merger Consideration in the form of Pubco Common Stock; provided , however, that
the Company may elect, in its sole discretion, prior to the Effective Time to receive in lieu of all or any number of shares of Pubco
Common Stock issuable as Merger Consideration to Sellers the same number of Pubco Common Stock Equivalents; provided , further ,
that in no event shall the aggregate number of shares of Pubco Common Stock and Pubco Common Stock Equivalents issued pursuant to this
Section 1.8 exceed the total number of shares that would otherwise constitute the Merger Consideration.

 1.9 Effect
of SPAC Merger on Issued and Outstanding Securities of SPAC and SPAC Merger Sub . At the Effective Time, by virtue of the SPAC Merger
and following the Conversion, and without any action on the part of any Party or the holders of securities of any SPAC Party or the Company:

 (a) SPAC
Public Units . At the Effective Time, each issued and outstanding SPAC Public Unit shall be automatically detached and the holder thereof
shall be deemed to hold one share of SPAC Common Stock and one-half (1/2) of one SPAC Public Warrant in accordance with the terms of the
applicable SPAC Public Unit, which underlying SPAC Securities shall then be converted in accordance with the applicable terms of this
 Section 1.9 below.

 (b) SPAC
Common Stock . At the Effective Time, each issued and outstanding share of SPAC Common Stock (other than those described in Section
1.9(d) below, but including those described in Section 1.9(a) above) shall be converted automatically into and thereafter represent
the right to receive one share of Pubco Common Stock; following which, all shares of SPAC Common Stock shall cease to be outstanding and
shall automatically be canceled and shall cease to exist.

 4

 (c) SPAC
Warrants . At the Effective Time, each issued and outstanding SPAC Public Warrant shall be converted into one Pubco Public Warrant
and each issued and outstanding SPAC Private Warrant shall be converted into one Pubco Private Warrant. At the Effective Time, SPAC Warrants
shall cease to be outstanding and shall automatically be canceled and retired and shall cease to exist. Each of the Pubco Public Warrants
shall have, and be subject to, substantially the same terms and conditions set forth in SPAC Public Warrants, and each of the Pubco Private
Warrants shall have, and be subject to, substantially the same terms and conditions set forth in SPAC Private Warrants, except that in
each case they shall represent the right to acquire shares of Pubco Common Stock in lieu of shares of SPAC Common Stock. At or prior to
the Effective Time, Pubco shall take all corporate action necessary to reserve for future issuance, and shall maintain such reservation
for so long as any of the Pubco Public Warrants or Pubco Private Warrants remain outstanding, a sufficient number of shares of Pubco Common
Stock for delivery upon the exercise of such Pubco Public Warrants or Pubco Private Warrants, as applicable.

 (d) Treasury
Stock . At the Effective Time, if there are any shares of capital stock of SPAC that are owned by SPAC as treasury shares or by any
direct or indirect Subsidiary of SPAC, such shares shall be canceled and extinguished without any conversion thereof or payment therefor.

 (e) SPAC
Merger Sub Stock . At the Effective Time, each share of common stock of SPAC Merger Sub outstanding immediately prior to the Effective
Time shall be converted into an equal number of shares of common stock of SPAC Surviving Subsidiary, with the same rights, powers and
privileges as the shares so converted and shall constitute the only outstanding shares of capital stock of SPAC Surviving Subsidiary.

 1.10 Effect
of Company Merger on Issued Securities of the Company and Company Merger Sub . At the Effective Time, by virtue of the Company Merger
and without any action on the part of any Party or the holders of securities of any SPAC Party or the Company:

 (a) Company
Interests . At the Effective Time, each Company Interest issued and outstanding immediately prior to the Effective Time (other than
the Company Interests described in Section 1.10(b) below) will be cancelled and cease to exist in exchange for the right to receive
the Merger Consideration as described in Section 1.8 . As of the Effective Time, each holder of Company Interests shall cease to
have any other rights with respect to the Company Interests, except as otherwise required under applicable Law.

 (b) Treasury
Interests. At the Effective Time, if there are any equity securities of the Company that are owned by the Company in treasury or any
equity securities of the Company owned by any direct or indirect Subsidiary of the Company immediately prior to the Effective Time, such
equity interests (collectively, the “ Excluded Interests ”) shall be canceled and shall cease to exist without
any conversion thereof or payment therefor.

 (c) Company
Convertible Securities. Any outstanding Company Convertible Security, if not exercised or converted prior to the Effective Time, shall
be cancelled, retired and terminated and cease to represent a right to acquire, be exchanged for or convert into Company Interests.

 (d) Company
Merger Sub Interests. At the Effective Time, each membership interest of Company Merger Sub outstanding immediately prior to the
Effective Time shall be converted into an equal number of membership interests of Company Surviving Subsidiary, with the same rights,
powers and privileges as the membership interests so converted and shall constitute the only equity interests in Company Surviving Subsidiary.

 5

 1.11 Effect
of Mergers on Issued and Outstanding Securities of Pubco . At the Effective Time, by virtue of the Mergers and without any action on
the part of any Party or the holders of securities of any SPAC Party or the Company, all of the shares of Pubco issued and outstanding
immediately prior to the Effective Time shall be canceled and extinguished without any conversion thereof or payment therefor.

 1.12 Sponsor
Payment . At the Closing, Pubco shall pay to Copley Acquisition Sponsors Limited, a British Virgin Islands company limited by shares
incorporated under the laws of the British Virgin Islands, in cash by wire transfer of immediately available funds, an amount equal to
Four Million U.S. Dollars ($4,000,000) (the “ Sponsor Payment ”).

 1.13 Tax
Consequences . It is intended by the Parties that the Mergers shall, collectively, constitute a transaction described in Section 351
of the Code.

 1.14 Taking
of Necessary Action; Further Action . If, at any time after the Effective Time, any further action is necessary or desirable to carry
out the purposes of this Agreement and to vest SPAC Surviving Subsidiary or Company Surviving Subsidiary with full right, title and possession
to all assets, property, rights, agreements, privileges, powers and franchises of SPAC Merger Sub and Company Merger Sub, respectively,
the then current officers and directors of SPAC Surviving Subsidiary and Pubco, and the then officers and board of managers of Company
Surviving Subsidiary shall take all such lawful and necessary action, so long as such action is not inconsistent with this Agreement.

 Article
II

CLOSING

 2.1 Closing .
Subject to the satisfaction or waiver of the conditions set forth in Article VII , the consummation of the transactions contemplated
by this Agreement (the “ Closing ”) shall take place at the offices of Winston Taylor, LLP (“ Winston ”),
counsel to SPAC, 800 Capitol St., Suite 2400, Houston, TX 77002, on a date and at a time to be agreed upon by SPAC and the Company, which
date shall be no later than the second (2 nd ) Business Day after all the Closing conditions to this Agreement have been satisfied
or waived, or at such other date, time or place (including remotely) as SPAC and the Company may agree (the date and time at which the
Closing is actually held being the “ Closing Date ”).

 Article
III

REPRESENTATIONS AND WARRANTIES OF SPAC

 Except as set forth in (i)
the disclosure schedules delivered by SPAC to the Company on the date hereof (the “ SPAC Disclosure Schedules ”),
the Section numbers of which are numbered to correspond to the Section numbers of this Agreement to which they refer, or (ii) the SEC
Reports that are available on the SEC’s website through EDGAR, SPAC represents and warrants to the Company, as follows:

 3.1 Organization
and Standing . SPAC is an exempted company duly incorporated, validly existing and in good standing under the Laws of the Cayman Islands.
SPAC has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being
conducted. SPAC is duly qualified or licensed and in good standing to do business in each jurisdiction in which the character of the property
owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary, except
where the failure to be so qualified or licensed or in good standing can be cured without material cost or expense. SPAC has heretofore
made available to the Company accurate and complete copies of its Organizational Documents, as currently in effect. SPAC is not in violation
of any provision of its Organizational Documents in any material respect.

 6

 3.2 Authorization;
Binding Agreement . SPAC has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document
to which it is a party, to perform SPAC’s obligations hereunder and thereunder and to consummate the transactions contemplated hereby
and thereby, subject to obtaining the Required SPAC Shareholder Approval. The execution and delivery of this Agreement and each Ancillary
Document to which it is a party and the consummation of the transactions contemplated hereby and thereby (a) have been duly and validly
authorized by the board of directors of SPAC and (b) other than the Required SPAC Shareholder Approval, no other corporate proceedings,
other than as set forth elsewhere in the Agreement, on the part of SPAC are necessary to authorize the execution and delivery of this
Agreement and each Ancillary Document to which it is a party or to consummate the transactions contemplated hereby and thereby. This Agreement
has been, and each Ancillary Document to which SPAC is a party shall be when delivered, duly and validly executed and delivered by SPAC
and, assuming the due authorization, execution and delivery of this Agreement and such Ancillary Documents by the other parties hereto
and thereto, constitutes, or when delivered shall constitute, the valid and binding obligation of SPAC, enforceable against SPAC in accordance
with its terms, except to the extent that enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization and
moratorium laws and other laws of general application affecting the enforcement of creditors’ rights generally or by any applicable
statute of limitation or by any valid defense of set-off or counterclaim, and the fact that equitable remedies or relief (including the
remedy of specific performance) are subject to the discretion of the court from which such relief may be sought (collectively, the “ Enforceability
Exceptions ”).

 3.3 Governmental
Approvals . No Consent of or with any Governmental Authority, on the part of SPAC is required to be obtained or made in connection
with the execution, delivery or performance by SPAC of this Agreement and each Ancillary Document to which it is a party or the consummation
by SPAC of the transactions contemplated hereby and thereby, other than (a) pursuant to Antitrust Laws, (b) such filings as contemplated
by this Agreement, (c) any filings required with NYSE or the SEC with respect to the transactions contemplated by this Agreement, (d)
applicable requirements, if any, of the Securities Act, the Exchange Act, and/ or any state “blue sky” securities Laws, and
the rules and regulations thereunder, (e) the filing of the Conversion Organizational Documents with the Cayman Registrar and the Delaware
Conversion Documents with the Delaware Secretary of State pursuant to the DGCL and (f) where the failure to obtain or make such Consents
or to make such filings or notifications, would not reasonably be expected to have a Material Adverse Effect on SPAC.

 3.4 Non-Contravention .
The execution and delivery by SPAC of this Agreement and each Ancillary Document to which it is a party, the consummation by SPAC of the
transactions contemplated hereby and thereby, and compliance by SPAC with any of the provisions hereof and thereof, will not (a) conflict
with or violate any provision of SPAC’s Organizational Documents, (b) contravene or conflict with or constitute a violation
of any provisions of Law or Order binding upon or applicable to SPAC, (c) subject to obtaining the Consents from Governmental Authorities
referred to in Section 3.3 hereof, and the waiting periods referred to therein having expired, and any condition precedent
to such Consent or waiver having been satisfied, conflict with or violate any Law, Order or Consent applicable to SPAC or any of its properties
or assets, or (d) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse
of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification
of, (iv) accelerate the performance required by SPAC under, (v) result in a right of termination or acceleration under, (vi) give rise
to any obligation to make payments or provide compensation under, (vii) result in the creation of any Lien upon any of the properties
or assets of SPAC under, (viii) give rise to any obligation to obtain any third party Consent or provide any notice to any Person or (ix)
give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule,
accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms,
conditions or provisions of, any SPAC Material Contract, except for any deviations from any of the foregoing clauses (c) or (d) that would
not reasonably be expected to have a Material Adverse Effect on SPAC.

 7

 3.5 Capitalization .

 (a) SPAC’s
authorized share capital is comprised of: (i) 166,500,000 SPAC Ordinary Shares, consisting of 150,000,000 SPAC Class A Ordinary Shares,
par value $0.0001 per share, of which 17,978,393 SPAC Class A Ordinary Shares are issued and outstanding as of the date of this Agreement,
and 15,000,000 SPAC Class B Ordinary Shares, par value $0.0001 per share, of which 5,750,000 SPAC Class B Ordinary Shares are issued and
outstanding as of the date of this Agreement, and (ii) 1,500,000 SPAC Preference Shares, par value $0.0001 per share, of which no shares
are issued and outstanding as of the date of this Agreement. All outstanding SPAC Securities are duly authorized, validly issued, fully
paid and non-assessable and are not subject to or issued in violation of any purchase option, right of first refusal, preemptive right,
subscription right or any similar right under any provision of the Act (prior to the Conversion), SPAC’s Organizational Documents
or any Contract to which SPAC is a party. None of the outstanding SPAC Securities has been issued in violation of any applicable securities
Laws.

 (b) Except
as set forth on Schedule 3.5(a) or Schedule 3.5(b) there are no (i) outstanding options, warrants, puts, calls, convertible
securities, preemptive or similar rights, (ii) bonds, debentures, notes or other Indebtedness having general voting rights or that are
convertible or exchangeable into securities having such rights or (iii) subscriptions or other rights, agreements, arrangements, Contracts
or commitments of any character (other than this Agreement and the Ancillary Documents), (A) relating to the issued or unissued shares
of SPAC or (B) obligating SPAC to issue, transfer, deliver or sell or cause to be issued, transferred, delivered, sold or repurchased
any options or shares or securities convertible into or exchangeable for such shares, or (C) obligating SPAC to grant, extend or enter
into any such option, warrant, call, subscription or other right, agreement, arrangement or commitment for such capital shares. Other
than the Redemption or as expressly set forth in this Agreement, there are no outstanding obligations of SPAC to repurchase, redeem or
otherwise acquire any shares of SPAC or to provide funds to make any investment (in the form of a loan, capital contribution or otherwise)
in any Person. Except as set forth on Schedule 3.5(b) , there are no shareholders agreements, voting trusts or other agreements
or understandings to which SPAC is a party with respect to the voting of any shares of SPAC.

 (c) All
Indebtedness of SPAC as of the date of this Agreement is disclosed on Schedule 3.5(c) . No Indebtedness of SPAC contains any restriction
upon (i) the prepayment of any of such Indebtedness, (ii) the incurrence of Indebtedness by SPAC or (iii) the ability of SPAC to grant
any Lien on its properties or assets.

 (d) Since
the date of formation of SPAC, and except as contemplated by this Agreement, SPAC has not declared or paid any distribution or dividend
in respect of its shares and has not repurchased, redeemed or otherwise acquired any of its shares, and SPAC’s board of directors
has not authorized any of the foregoing.

 8

 3.6 SEC
Filings and SPAC Financials .

 (a) SPAC,
since the IPO, has filed all forms, reports, schedules, statements, registration statements, prospectuses and other documents required
to be filed or furnished by SPAC with the SEC under the Securities Act and/or the Exchange Act, together with any amendments, restatements
or supplements thereto, and will file all such forms, reports, schedules, statements and other documents required to be filed subsequent
to the date of this Agreement and SPAC has not taken any action prohibited by Section 402 of SOX regarding this Section 3.6(a) .
Except to the extent available on the SEC’s web site through EDGAR, SPAC has delivered to the Company copies in the form filed with
the SEC of all of the following: (i) SPAC’s annual reports on Form 10-K for each fiscal year of SPAC beginning with the first year
SPAC was required to file such a form, (ii) SPAC’s quarterly reports on Form 10-Q for each fiscal quarter that SPAC filed such reports
to disclose its quarterly financial results in each of the fiscal years of SPAC referred to in clause (i) above, (iii) all other forms,
reports, registration statements, prospectuses and other documents (other than preliminary materials) filed by SPAC with the SEC since
the beginning of the first fiscal year referred to in clause (i) above (the forms, reports, registration statements, prospectuses and
other documents referred to in clauses (i), (ii) and (iii) above, whether or not available through EDGAR, are, collectively, the “ SEC
Reports ”) and (iv) all certifications and statements required by (A) Rules 13a-14 or 15d-14 under the Exchange Act, and
(B) 18 U.S.C. §1350 (Section 906 of SOX) with respect to any report referred to in clause (i) above (collectively, the “ Public
Certifications ”). As of their respective dates, the SEC Reports (x) were prepared in all material respects in accordance
with the requirements of the Securities Act and the Exchange Act, as the case may be, and the rules and regulations thereunder and (y)
did not, as of their respective effective dates (in the case of SEC Reports that are registration statements filed pursuant to the requirements
of the Securities Act) and at the time they were filed with the SEC (in the case of all other SEC Reports) contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements made therein,
in the light of the circumstances under which they were made, not misleading. As of the date of this Agreement, (A) SPAC Public Units,
SPAC Class A Ordinary Shares, and SPAC Public Warrants are listed on NYSE, (B) SPAC has not received any written deficiency notice from
NYSE relating to the continued listing requirements of such SPAC Securities, (C) there are no Actions pending or, to the Knowledge of
SPAC, threatened against SPAC by the Financial Industry Regulatory Authority with respect to any intention by such entity to suspend,
prohibit or terminate the quoting of such SPAC Securities on NYSE and (D) such SPAC Securities are in compliance with all of the applicable
corporate governance rules of NYSE.

 (b) SPAC
maintains disclosure controls and procedures required by Rules 13a-15 or Rule 15d-15 under the Exchange Act; such controls and procedures
are reasonably designed to ensure that all material information concerning SPAC and other material information required to be disclosed
by SPAC in the reports and other documents that it files or furnishes under the Exchange Act is made known on a timely basis to the individuals
responsible for the preparation of SPAC’s SEC filings and other public disclosure documents.

 9

 (c) The
financial statements and notes of SPAC contained or incorporated by reference in the SEC Reports (the “ SPAC Financials ”),
fairly present in all material respects the financial position and the results of operations, changes in shareholders’ equity, and
cash flows of SPAC at the respective dates of and for the periods referred to in the SPAC Financials, all in accordance with (i) GAAP
methodologies applied on a consistent basis throughout the periods involved and (ii) Regulation S-X or Regulation S-K, as applicable (except
as may be indicated in the notes thereto and for the omission of notes and audit adjustments in the case of unaudited quarterly financial
statements to the extent permitted by Regulation S-X or Regulation S-K, as applicable).

 (d) Except
to the extent reflected or reserved against in SPAC Financials, SPAC has not incurred any Liabilities or obligations of the type required
to be reflected on a balance sheet in accordance with GAAP that are not adequately reflected or reserved on or provided for in SPAC Financials,
other than Liabilities of the type required to be reflected on a balance sheet in accordance with GAAP that have been incurred since SPAC’s
formation in the ordinary course of business. The SPAC has no off-balance sheet arrangements.

 (e) There
are no outstanding loans or other extensions of credit made by SPAC to any executive officer (as defined in Rule 3b-7 under the Exchange
Act) or director of SPAC.

 3.7 Absence
of Certain Changes . As of the date of this Agreement, SPAC has, (a) since its formation, conducted no business other than its formation,
the public offering of its securities (and the related private offerings), public reporting and its search for an initial Business Combination
as described in the IPO Prospectus (including the investigation of the Target Companies and the negotiation and execution of this Agreement)
and related activities and (b) since December 31, 2025 through the date of this Agreement, not been subject to a Material Adverse Effect
on SPAC.

 3.8 Compliance
with Laws . SPAC is, and has since its formation been, in compliance with all Laws applicable to it and the conduct of its business
except for such noncompliance which would not reasonably be expected to have a Material Adverse Effect on SPAC, and SPAC has not received
written notice alleging any violation of applicable Law in any material respect by SPAC.

 3.9 Actions;
Orders; Permits . There is no pending or, to the Knowledge of SPAC, threatened material Action to which SPAC is subject which would
reasonably be expected to have a Material Adverse Effect on SPAC. There is no material Action that SPAC has pending against any other
Person. SPAC is not subject to any material Orders of any Governmental Authority, nor are any such Orders pending. SPAC holds all material
Permits necessary to lawfully conduct its business as presently conducted, and to own, lease and operate its assets and properties, all
of which are in full force and effect, except where the failure to hold such Consent or for such Consent to be in full force and effect
would not reasonably be expected to have a Material Adverse Effect on SPAC.

 3.10 Taxes
and Returns .

 (a) SPAC
has timely filed, or caused to be timely filed, all material Tax Returns required to be filed by it, which Tax Returns are accurate and
complete in all material respects, and has paid, collected or withheld, or caused to be paid, collected or withheld, all material Taxes
required to be paid, collected or withheld, other than such Taxes for which adequate reserves in SPAC Financials have been established
in accordance with GAAP. Schedule 3.10(a) sets forth each jurisdiction where SPAC files or is required to file a Tax Return. There
are no audits, examinations, investigations or other proceedings pending against SPAC in respect of any Tax, and SPAC has not been notified
in writing of any proposed Tax claims or assessments against SPAC (other than, in each case, claims or assessments for which adequate
reserves in SPAC Financials have been established in accordance with GAAP or are immaterial in amount). There are no Liens with respect
to any Taxes upon any of SPAC’s assets, other than Permitted Liens. SPAC has no outstanding waivers or extensions of any applicable
statute of limitations to assess any material amount of Taxes. There are no outstanding requests by SPAC for any extension of time within
which to file any Tax Return or within which to pay any Taxes shown to be due on any Tax Return.

 10

 (b) Since
the date of its incorporation, SPAC has not (i) changed any Tax accounting methods, policies or procedures except as required by a change
in Law, (ii) made, revoked or amended any material Tax election, (iii) filed any amended Tax Returns or claim for refund or (iv) entered
into any closing agreement affecting or otherwise settled or compromised any material Tax Liability or refund.

 (c) To
the Knowledge of SPAC, there are no facts or circumstances that would reasonably be expected to prevent the Mergers from qualifying as
an exchange described in Section 351 of the Code.

 3.11 Employees
and Employee Benefit Plans . SPAC does not (a) have any paid employees or (b) maintain, sponsor, contribute to or otherwise have any
Liability under, any Benefit Plans.

 3.12 Properties .
SPAC does not own, license or otherwise have any right, title or interest in any material Intellectual Property. SPAC does not own or
lease any material real property or material Personal Property.

 3.13 Material
Contracts .

 (a) Except
as set forth on Schedule 3.13(a) , other than this Agreement and the Ancillary Documents, there are no Contracts to which SPAC is
a party or by which any of its properties or assets may be bound, subject or affected, which creates or imposes a Liability greater than
$250,000 (each, a “ SPAC Material Contract ”). All SPAC Material Contracts have been made available to the Company
other than those that are exhibits to the SEC Reports.

 (b) With
respect to each SPAC Material Contract: (i) the SPAC Material Contract was entered into at arms’ length and in the ordinary course
of business, (ii) the SPAC Material Contract is legal, valid, binding and enforceable in all material respects against SPAC and, to the
Knowledge of SPAC, the other parties thereto, and is in full force and effect (except, in each case, as such enforcement may be limited
by the Enforceability Exceptions),(iii) SPAC is not in breach or default in any material respect, and no event has occurred that with
the passage of time or giving of notice or both would constitute such a breach or default in any material respect by SPAC, or permit termination
or acceleration by the other party, under such SPAC Material Contract, and (iv) to the Knowledge of SPAC, no other party to any SPAC Material
Contract is in breach or default in any material respect, and no event has occurred that with the passage of time or giving of notice
or both would constitute such a breach or default by such other party, or permit termination or acceleration by SPAC under any SPAC Material
Contract.

 3.14 Transactions
with Affiliates . Schedule 3.14 sets forth a true, correct and complete list of the Contracts and arrangements that are in existence
as of the date of this Agreement under which there are any existing or future Liabilities or obligations between SPAC and any (a) present
or former director, officer or employee or Affiliate of SPAC, or any immediate family member of any of the foregoing, or (b) record or
beneficial owner of more than ten percent (10%) of SPAC’s outstanding capital stock as of the date hereof.

 3.15 Investment
Company Act . SPAC is not an “investment company” or a Person directly or indirectly “controlled” by or acting
on behalf of an “investment company”, or required to register as an “investment company”, in each case within
the meaning of the Investment Company Act of 1940, as amended (the “ Investment Company Act ”).

 11

 3.16 Finders
and Brokers . Except as set forth on Schedule 3.16 , no broker, finder or investment banker is entitled to any brokerage, finder’s
or other fee or commission from SPAC, the Target Companies or any of their respective Affiliates in connection with the transactions contemplated
hereby based upon arrangements made by or on behalf of SPAC.

 3.17 Certain
Business Practices .

 (a) Neither
SPAC, nor, to the Knowledge of SPAC, any of its Representatives acting on its behalf, has (i) used any funds for unlawful contributions,
gifts, entertainment or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic
government officials or employees, to foreign or domestic political parties or campaigns or violated any provision of the U.S. Foreign
Corrupt Practices Act of 1977 or any other local or foreign anti-corruption or bribery Law, (iii) made any other unlawful payment or (iv)
since the formation of SPAC, directly or indirectly, given or agreed to give any unlawful gift or similar benefit in any material amount
to any customer, supplier, governmental employee or other Person who is or may be in a position to help or hinder SPAC or assist it in
connection with any actual or proposed transaction.

 (b) The
operations of SPAC are and have been conducted at all times in material compliance with money laundering statutes in all applicable jurisdictions,
the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by
any Governmental Authority, and no Action involving SPAC with respect to any of the foregoing is pending or, to the Knowledge of SPAC,
threatened.

 (c) None
of SPAC or any of its directors or officers, or, to the Knowledge of SPAC, any other Representative acting on behalf of SPAC is currently
(i) identified on the specially designated nationals or other blocked person list or otherwise currently subject to any U.S. sanctions
administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“ OFAC ”), the U.S. Department
of State, or other applicable Governmental Authority; (ii) organized, resident, or located in, or a national of a comprehensively sanctioned
country; or (iii) in the aggregate, fifty percent (50%) or greater owned, directly or indirectly, or otherwise controlled, by a person
identified in (i) or (ii); and SPAC has not, directly or indirectly, used any funds, or loaned, contributed or otherwise made available
such funds to any Subsidiary, joint venture partner or other Person, in connection with any sales or operations in any other country sanctioned
by OFAC or for the purpose of financing the activities of any Person currently subject to, or otherwise in violation of, any U.S. sanctions
administered by OFAC or the U.S. Department of State in the last five (5) fiscal years.

 3.18 SPAC
Trust Account . As of March 31, 2026, the Trust Account had a balance of $179,525,293.60. Such monies are invested solely in United
States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act or money market funds
meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, and held in trust by the Trustee pursuant to
the Trust Agreement. The Trust Agreement is valid and in full force and effect and enforceable in accordance with its terms (subject to
the Enforceability Exceptions) and has not been amended or modified. SPAC has complied in all material respects with the terms of the
Trust Agreement and is not in material breach thereof or material default thereunder and there does not exist under the Trust Agreement
any event which, with the giving of notice or the lapse of time, would constitute such a material breach or material default by SPAC or,
to the Knowledge of SPAC, by the Trustee. There are no separate contracts, agreements, side letters or other agreements or understandings
(whether written or unwritten, express or implied) between SPAC and the Trustee that would cause the description of the Trust Agreement
in the SEC Reports to be inaccurate in any material respect and/or that would entitle any Person (other than the underwriters of the IPO,
Public Shareholders who shall have elected to redeem their SPAC Class A Ordinary Shares pursuant to SPAC Organizational Documents (or
in connection with an extension of SPAC’s deadline to consummate a Business Combination) or Governmental Authorities for Taxes)
to any portion of the proceeds in the Trust Account. Prior to the Closing, none of the funds held in the Trust Account may be released
except as described in the Trust Agreement and the IPO Prospectus. There are no Actions pending or, to the knowledge of SPAC, threatened
with respect to the Trust Account.

 12

 3.19 Exclusivity
of Representations .

 (a) Neither
the Company nor its Representatives has made any representation or warranty as to the Target Companies, or this Agreement, except as expressly
set forth in this Agreement (including the related portions of the Company Disclosure Schedules) or in any certificate delivered to SPAC
pursuant hereto, or with respect to the information provided by or on behalf of the Company for the Registration Statement.

 (b) Company
specifically disclaims that it is relying upon or has relied upon any other representations and warranties that may have been made by
any Person and acknowledges and agrees that SPAC, Pubco and the Merger Subs have specifically disclaimed any such other representations
and warranties.

 3.20 Information Supplied .
None of the information supplied or to be supplied by SPAC expressly for inclusion or incorporation by reference: (a) in any current
report on Form 8-K, and any exhibits thereto or any other report, form, registration or other filing made with any Governmental Authority
or stock exchange with respect to the transactions contemplated by this Agreement or any Ancillary Documents; (b) in the Registration
Statement; or (c) in the mailings or other distributions to SPAC’s shareholders and/or prospective investors with respect to the
consummation of the transactions contemplated by this Agreement or in any amendment to any of documents identified in (a) through (c),
will, when filed, made available, mailed or distributed, as the case may be, contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they are made, not misleading (provided, if such information is revised by any subsequently filed amendment or supplement
to the Registration Statement prior to the time the Registration Statement is declared effective by the SEC, this clause (a) shall solely
refer to the time of such subsequent revision or supplement). None of the information supplied or to be supplied by SPAC expressly for
inclusion or incorporation by reference in any of the Signing Press Release, the Signing Filing, the Closing Press Release and the Closing
Filing will, when filed or distributed, as applicable, contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
are made, not misleading. Notwithstanding the foregoing, SPAC makes no representation, warranty or covenant with respect to any information
supplied by or on behalf of the Target Companies or its Affiliates.

 Article
IV

 REPRESENTATIONS AND WARRANTIES OF

PUBCO AND THE MERGER SUBS

 Each of Pubco and the Merger
Subs, jointly and severally, represents and warrants to the Company, as follows:

 4.1 Organization
and Standing . Pubco and SPAC Merger Sub are each corporations duly incorporated, validly existing and in good standing under the Laws
of the State of Delaware and Company Merger Sub is a limited liability company duly organized, validly existing and in good standing under
the Laws of Delaware. Each of Pubco and the Merger Subs has all requisite corporate or limited liability power, as applicable, and authority
to own, lease and operate its properties and to carry on its business as now being conducted. Each of Pubco and the Merger Subs is duly
qualified or licensed and in good standing to do business in each jurisdiction in which the character of the property owned, leased or
operated by it or the nature of the business conducted by it makes such qualification or licensing necessary, except where the failure
to be so qualified or licensed would not individually or in the aggregate reasonably be expected to have a material impact on the ability
of Pubco or any Merger Sub on a timely basis to consummate the transactions contemplated by this Agreement. Pubco has heretofore made
available to SPAC and the Company accurate and complete copies of the Organizational Documents of Pubco and the Merger Subs, each as currently
in effect. Neither Pubco nor any Merger Sub is in violation of any provision of its Organizational Documents in any material respect.

 13

 4.2 Authorization;
Binding Agreement . Subject to the adoption of the Amended Pubco Charter, each of Pubco and the Merger Subs has all requisite corporate
or limited liability power, as applicable, and authority to execute and deliver this Agreement and each Ancillary Document to which it
is a party, to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The
sole stockholder of Pubco, Pubco in its capacity as sole stockholder of SPAC Merger Sub and Pubco in its capacity as sole member and manager
of Company Merger Sub has authorized the execution, delivery and performance of this Agreement and the Ancillary Documents and the consummation
of the Mergers and the other transactions contemplated by this Agreement. The execution and delivery of this Agreement and each Ancillary
Document to which it is a party and the consummation of the transactions contemplated hereby and thereby have been duly and validly authorized
by the board of directors of Pubco and SPAC Merger Sub and no other corporate proceedings, other than as expressly set forth elsewhere
in this Agreement (including the adoption of the Amended Pubco Charter and the approval by the equity holders of Pubco and each Merger
Sub), on the part of Pubco or Merger Subs are necessary to authorize the execution and delivery of this Agreement and each Ancillary Document
to which it is a party or to consummate the transactions contemplated hereby and thereby. This Agreement has been, and each Ancillary
Document to which Pubco or the Merger Subs is a party has been or shall be when delivered, duly and validly executed and delivered by
such Party and, assuming the due authorization, execution and delivery of this Agreement and such Ancillary Documents by the other parties
hereto and thereto, constitutes, or when delivered shall constitute, the valid and binding obligation of such Party, enforceable against
such Party in accordance with its terms, subject to the Enforceability Exceptions.

 4.3 Governmental
Approvals . No Consent of or with any Governmental Authority, on the part of Pubco or the Merger Subs is required to be obtained or
made in connection with the execution, delivery or performance by such Party of this Agreement and each Ancillary Document to which it
is a party or the consummation by such Party of the transactions contemplated hereby and thereby, other than (a) pursuant to Antitrust
Laws, (b) such filings as contemplated by this Agreement, (c) any filings required with NYSE or the
SEC with respect to the transactions contemplated by this Agreement, (d) applicable requirements, if any, of the Securities Act, the Exchange
Act, and/ or any state “blue sky” securities Laws, and the rules and regulations thereunder, and (e) where the failure to
obtain or make such Consents or to make such filings or notifications, would not, individually or in the aggregate, reasonably be expected
to have a material impact on the ability of Pubco on a timely basis to consummate the transactions contemplated by this Agreement.

 4.4 Non-Contravention .
The execution and delivery by Pubco and the Merger Subs of this Agreement and each Ancillary Document to which it is a party, the consummation
by such Party of the transactions contemplated hereby and thereby, and compliance by such Party with any of the provisions hereof and
thereof, will not (a) subject to the adoption of the Amended Pubco Charter, conflict with or violate any provision of such Party’s
Organizational Documents, (b) subject to obtaining the Consents from Governmental Authorities referred to in Section 4.3 hereof,
and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any Law, Order or Consent applicable
to such Party or any of its properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default
(or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal,
suspension, cancellation or modification of, (iv) accelerate the performance required by such Party under, (v) result in a right of termination
or acceleration under, (vi) give rise to any obligation to make payments or provide compensation under, (vii) result in the creation of
any Lien upon any of the properties or assets of such Party under, (viii) give rise to any obligation to obtain any third party Consent
or provide any notice to any Person or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback,
penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation
or other term under, any of the terms, conditions or provisions of, any material Contract of such Party, except for any deviations from
any of the foregoing clauses (a), (b) or (c) that would not, individually or in the aggregate, reasonably be expected to have a material
impact on the ability of Pubco on a timely basis to consummate the transactions contemplated by this Agreement.

 14

 4.5 Capitalization .
As of the Closing Date, Pubco and the Merger Subs will have the capitalization stated in their respective Organizational Documents. Prior
to giving effect to the transactions contemplated by this Agreement, other than the Merger Subs, Pubco does not have any Subsidiaries
or own any equity interests in any other Person.

 4.6 Ownership
of Pubco Common Stock . (i) All shares of Pubco Common Stock to be issued and delivered in accordance with Article I to the
Sellers shall be, upon issuance and delivery of such shares, duly authorized, validly issued, fully paid, non-assessable and free and
clear of all Liens, and (ii) upon issuance and delivery of such shares to the Sellers, each Seller shall have good and valid title to
its portion of such shares, in each case of clauses (i) and (ii), other than restrictions arising from applicable securities Laws, the
Ancillary Documents, the Amended Pubco Charter, the provisions of this Agreement and any Liens incurred by the Sellers, and (iii) the
issuance and sale of such shares pursuant hereto will not be subject to or give rise to any preemptive rights or rights of first refusal.

 4.7 Pubco
and Merger Sub Activities . Since their formation, Pubco and the Merger Subs have not engaged in any business activities other than
as contemplated by this Agreement, do not own directly or indirectly any ownership, equity, profits or voting interest in any Person (other
than Pubco’s one hundred percent (100%) ownership of the Merger Subs) and have no assets or Liabilities except those incurred in
connection with this Agreement and the Ancillary Documents to which they are a party and the transactions contemplated by this Agreement,
and, other than this Agreement and the Ancillary Documents to which they are a party, Pubco and the Merger Subs are not party to or bound
by any Contract.

 Article
V

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 Except as set forth in the
disclosure schedules delivered by the Company to SPAC on the date hereof (the “ Company Disclosure Schedules ”),
the Section numbers of which are numbered to correspond to the Section numbers of this Agreement to which they refer (provided, however,
that an item disclosed in any Section of the Company Disclosure Schedules shall be deemed to have been disclosed with respect to all other
Sections of this Article V to which the relevance of such disclosure is reasonably apparent on its face), the Company hereby represents
and warrants to SPAC, as of the date hereof and as of the Closing, as follows:

 5.1 Organization
and Standing . The Company is a limited liability company duly organized, validly existing and in good standing under the Laws of the
State of Delaware and has all requisite limited liability power and authority to own, lease and operate its properties and to carry on
its business as now being conducted. Each Subsidiary of the Company is a corporation or other entity duly organized, validly existing
and in good standing under the Laws of its jurisdiction of organization and has all requisite corporate or limited liability company power
and authority, as applicable, to own, lease and operate its properties and to carry on its business as now being conducted. Each Target
Company is duly qualified or licensed and in good standing in the jurisdiction in which it is incorporated or registered and in each other
jurisdiction where it does business or operates to the extent that the character of the property owned, or leased or operated by it or
the nature of the business conducted by it makes such qualification or licensing necessary, except where failure to be so qualified or
licensed or in good standing can be cured without material cost or expense. Schedule 5.1 lists all jurisdictions in which any Target
Company is qualified to conduct business and all names other than its legal name under which any Target Company does business. The Company
has provided to SPAC accurate and complete copies of its Organizational Documents and the Organizational Documents of each of its Subsidiaries,
each as amended to date and as currently in effect. No Target Company is in violation of any provision of its Organizational Documents
in any material respect.

 15

 5.2 Authorization;
Binding Agreement . The Company has all requisite limited liability company power and authority to execute and deliver this Agreement
and each Ancillary Document to which it is or is required to be a party, to perform the Company’s obligations hereunder and thereunder
and to consummate the transactions contemplated hereby and thereby, subject to obtaining the Required Company Member Approval. The execution
and delivery of this Agreement and each Ancillary Document to which the Company is or is required to be a party and the consummation of
the transactions contemplated hereby and thereby, (a) have been duly and validly authorized by the Company’s board of managers (or
manager or managing member(s), as applicable) in accordance with the Company Operating Agreement any other applicable Law or any Contract
to which the Company or any of its equity holders is a party or by which it or its securities are bound and (b) other than the Required
Company Member Approval, no other corporate proceedings on the part of the Company are necessary to authorize the execution and delivery
of this Agreement and each Ancillary Document to which it is a party or to consummate the transactions contemplated hereby and thereby.
This Agreement has been, and each Ancillary Document to which the Company is or is required to be a party has been or shall be when delivered,
duly and validly executed and delivered by the Company and assuming the due authorization, execution and delivery of this Agreement and
any such Ancillary Document by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the legal, valid
and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions.
The Company’s board of managers (or manager or managing member(s), as applicable), by resolutions duly adopted at a meeting duly
called and held or by unanimous written consent (i) determined that this Agreement and the Mergers and the other transactions contemplated
hereby are advisable, fair to, and in the best interests of, the Company and its members, (ii) approved this Agreement and the Mergers
and the other transactions contemplated by this Agreement in accordance with the DLLCA, (iii) directed that this Agreement and the other
matters required for member approval be submitted to the Company’s members for adoption and (iv) resolved to recommend that the
Company’s members adopt and approve this Agreement and the other matters requiring such member approval. The Seller Support Agreements
delivered by the Company include holders of Company Interests representing at least the Required Company Member Approval, and such Seller
Support Agreements are in full force and effect.

 5.3 Capitalization .

 (a) All
of the issued and outstanding Company Interests are set forth on Schedule 5.3(a) , along with the beneficial and record owners thereof,
all of which Company Interests and other equity interests are owned free and clear of any Liens other than those imposed under the Company
Operating Agreement or by applicable securities Laws. The issued and outstanding Company Interests constitute all of the outstanding equity
interests of the Company. All of the outstanding Company Interests and other equity interests of the Company have been duly authorized,
are fully paid and non-assessable and not in violation of any purchase option, right of first refusal, preemptive right, subscription
right or any similar right under any provision of the DLLCA, any other applicable Law, the Company Operating Agreement or any Contract
to which the Company is a party or by which it or its securities are bound. The Company does not directly or indirectly hold any Company
Interests or other equity interests of the Company in its treasury. All of the Company’s securities have been granted, offered,
sold and issued in compliance with all applicable securities Laws. The rights, privileges and preferences of the Company Interests are
as stated in the Company Operating Agreement and as provided by the DLLCA.

 16

 (b) There
are no Company Convertible Securities, or preemptive rights or rights of first refusal or first offer, nor are there any Contracts, commitments,
arrangements or restrictions to which the Company or any of its equity holders is a party or bound relating to any equity securities of
the Company, whether or not outstanding. There are no issued, reserved for issuance, outstanding or authorized option, restricted unit
award, restricted interest award, profits interest, profit participation, equity appreciation, phantom equity, or equity-based award or
similar rights with respect to the Company. Except as set forth on Schedule 5.3(b) , there are no voting trusts, proxies, shareholder
agreements or any other agreements or understandings with respect to the voting of the Company’s equity interests. Except as set
forth in the Company Operating Agreement, there are no outstanding contractual obligations of the Company to repurchase, redeem or otherwise
acquire any equity interests or securities of the Company, nor has the Company granted any registration rights to any Person with respect
to the Company’s equity securities. All of the Company’s securities have been granted, offered, sold and issued in compliance
with all applicable securities Laws. As a result of the consummation of the transactions contemplated by this Agreement, no equity interests
of the Company are issuable and no rights in connection with any interests, warrants, rights, options or other securities of the Company
accelerate or otherwise become triggered (whether as to vesting, exercisability, convertibility or otherwise).

 (c) Since
January 1, 2025, the Company has not declared or paid any distribution or dividend in respect of its equity interests and has not repurchased,
redeemed or otherwise acquired any equity interests of the Company, and the members of the Company have not authorized any of the foregoing.

 5.4 Subsidiaries .
 Schedule 5.4 sets forth the name of each Subsidiary of the Company, and with respect to each Subsidiary (a) its jurisdiction of
organization, (b) its authorized shares or other equity interests (if applicable), (c) the number of issued and outstanding shares or
other equity interests and the record holders and beneficial owners thereof and (d) its Tax election to be treated as a corporate or a
disregarded entity under the Code and any state or applicable non-U.S. Tax laws, if any. All of the outstanding equity securities of each
Subsidiary of the Company are duly authorized and validly issued, fully paid and non-assessable (if applicable), and were offered, sold
and delivered in compliance with all applicable securities Laws, and owned by one or more of the Target Companies free and clear of all
Liens (other than those, if any, imposed by such Subsidiary’s Organizational Documents or by applicable securities Laws). There
are no Contracts to which the Company or any of its Affiliates is a party or bound with respect to the voting (including voting trusts
or proxies) of the equity interests of any Subsidiary of the Company other than the Organizational Documents of any such Subsidiary. Except
as listed on Schedule 5.4 , there are no outstanding or authorized options, warrants, rights, agreements, subscriptions, convertible
securities or commitments to which any Subsidiary of the Company is a party or which are binding upon any Subsidiary of the Company providing
for the issuance or redemption of any equity interests of any Subsidiary of the Company. There are no issued, reserved for issuance, outstanding
or authorized option, restricted unit award, restricted interest award, profits interest, equity appreciation, phantom equity, profit
participation, or equity-based award or similar rights granted by any Subsidiary of the Company. No Target Company has any limitation,
whether by Contract, Order or applicable Law, on its ability to make any distributions or dividends to its equity holders or repay any
debt owed to another Target Company. Except for the equity interests of the Subsidiaries listed on Schedule 5.4(a) , the Company
does not own or have any rights to acquire, directly or indirectly, any equity interests of, or otherwise Control, any Person. None of
the Company or its Subsidiaries is a participant in any joint venture, partnership or similar arrangement. There are no outstanding contractual
obligations of a Target Company to provide funds to, or make any investment (in the form of a loan, capital contribution or otherwise)
in, any other Person.

 17

 5.5 Governmental
Approvals . Except as otherwise described on Schedule 5.5 , no Consent of or with any Governmental Authority on the part of any
Target Company is required to be obtained or made in connection with the execution, delivery or performance by the Company of this Agreement
or any Ancillary Documents or the consummation by the Company of the transactions contemplated hereby or thereby other than (a) such filings
as are expressly contemplated by this Agreement or (b) pursuant to Antitrust Laws.

 5.6 Non-Contravention .
Except as otherwise described on Schedule 5.6 , the execution and delivery by the Company (or any other Target Company, as applicable)
of this Agreement and each Ancillary Document to which any Target Company is or is required to be a party or otherwise bound, and the
consummation by any Target Company of the transactions contemplated hereby and thereby and compliance by any Target Company with any of
the provisions hereof and thereof, will not (a) conflict with or violate any provision of any Target Company’s Organizational Documents,
(b) subject to obtaining the Consents from Governmental Authorities referred to in Section 5.5 hereof, the waiting periods referred
to therein having expired, and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any Law,
Order or Consent applicable to any Target Company or any of its Company Permits, material properties or assets, or (c) (i) violate, conflict
with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a
default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance
required by any Target Company under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to
make payments or provide compensation under, (vii) result in the creation of any Lien upon any of the properties or assets of any Target
Company under, (viii) give rise to any obligation to obtain any third party Consent or provide any notice to any Person or (ix) give any
Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate
the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions
or provisions of any Company Permit or Company Material Contract, except for any deviations from any of the foregoing clauses (a), (b)
or (c) that would not, individually or in the aggregate, reasonably be expected to have a material impact on the ability of the Company
on a timely basis to consummate the transactions contemplated by this Agreement.

 5.7 Financial
Statements .

 (a) Schedule
5.7(a) contains true and correct copies of the Unaudited Financial Statements. The Unaudited Financial Statements (A) were prepared
from the books and records of the Target Companies as of the times and for the periods referred to therein, (B) were prepared in accordance
with GAAP, consistently applied throughout and among the periods involved (except as may be indicated in the notes thereto), and (C) fairly
present in all material respects the consolidated financial position of the Target Companies as of the respective dates thereof and the
consolidated results of the operations of the Target Companies for the periods indicated.

 (b) The
Target Companies do not have any Indebtedness other than the Indebtedness set forth on Schedule 5.7(b) , which schedule sets forth
the amounts (including principal and any accrued but unpaid interest or other obligations) with respect to such Indebtedness. Except as
disclosed on Schedule 5.7(b) , no Indebtedness of any Target Company contains any restriction upon (i) the prepayment of any of
such Indebtedness, (ii) the incurrence of Indebtedness by any Target Company, or (iii) the ability of the Target Companies to grant any
Lien on their respective properties or assets.

 18

 (c) All
of the financial books and records of the Target Companies are complete and accurate in all material respects and have been maintained
in the ordinary course consistent with past practice and in accordance with applicable Laws. No Target Company has been subject to or
involved in any material fraud that involves management or other employees who have a significant role in the internal controls over financial
reporting of any Target Company. To the Knowledge of the Company, no Target Company employee has engaged in any material fraud with respect
to the business activities or operations of any Target Company. In the past three (3) years, no Target Company or its Representatives
has received any written complaint, allegation, assertion or claim regarding the accounting or auditing practices, procedures, methodologies
or methods of any Target Company or its internal accounting controls, including any material written complaint, allegation, assertion
or claim that any Target Company has engaged in questionable accounting or auditing practices.

 (d) Except
as set forth on Schedule 5.7(d) , no Target Company is subject to any Liabilities or obligations required to be reflected on a balance
sheet prepared in accordance with GAAP, except for those that are either (i) adequately reflected or reserved on or provided for in the
consolidated balance sheet of the Company and its Subsidiaries as of December 31, 2025 and contained in the Company Financials or (ii)
not material and that were incurred after December 31, 2025 in the ordinary course of business consistent with past practice (other than
Liabilities for breach of any Contract or violation of any Law).

 (e) All
accounts, notes and other receivables, whether or not accrued, and whether or not billed, of the Target Companies (the “ Accounts
Receivable ”) arose from sales actually made or services actually performed in the ordinary course of business and represent
valid obligations to a Target Company arising from its business.

 5.8 Absence
of Certain Changes . Except as set forth on Schedule 5.8 , since December 31, 2025, each Target Company has (a) conducted its
business only in the ordinary course of business consistent with past practice, (b) not been subject to a Material Adverse Effect and
(c) has not taken any action or committed or agreed to take any action that would be prohibited by Section 6.2(b) (without giving
effect to Schedule 6.2 ) if such action were taken on or after the date hereof without the consent of SPAC.

 5.9 Compliance
with Laws . Since January 1, 2023, no Target Company is or has been in material conflict or material non-compliance with, or in material
default or violation of, nor has any Target Company received, since January 1, 2023, any written or, to the Knowledge of the Company,
oral notice of any material conflict or non-compliance with, or material default or violation of, any applicable Laws by which it or any
of its properties, assets, employees, business or operations are or were bound or affected.

 5.10 Company
Permits . Each Target Company (and its employees or contractors who are legally required to be licensed by a Governmental Authority
in order to perform his or her duties with respect to his or her employment or engagement with any Target Company), holds all Permits
necessary to lawfully conduct in all material respects its business as presently conducted, and as currently contemplated to be conducted,
and to own, lease and operate its assets and properties (collectively, the “ Company Permit s”). The Company has
made available to SPAC true, correct and complete copies of all material Company Permits, all of which material Company Permits are listed
on Schedule 5.10 . All of the Company Permits are in full force and effect, and no suspension or cancellation of any of the Company
Permits is pending or threatened in writing. No Target Company is in violation in any material respect of the terms of any Company Permit,
and no Target Company has received any written notice of any Actions relating to the revocation or modification, of any Company Permit.

 19

 5.11 Litigation .
Except as described on Schedule 5.11 , there is no (a) Action of any nature currently pending or threatened in writing, and no such
Action has been brought or threatened in writing in the past three (3) years; or (b) Order now pending or outstanding or that was rendered
by a Governmental Authority in the past three (3) years, in either case of (a) or (b) by or against any Target Company, its current or
former directors, managers or officers (provided, that any litigation involving the directors or officers of a Target Company must be
related to the Target Company’s business, equity securities or assets), its business, equity securities or assets. The items listed
on Schedule 5.11 , if finally determined adversely to the Target Companies, will not have, either individually or in the aggregate,
a Material Adverse Effect upon the Target Companies taken as a whole. In the past three (3) years, none of the current officers, senior
management, managers or directors of any Target Company have been charged with, indicted for, arrested for, or convicted of any felony
or any crime involving fraud.

 5.12 Material
Contracts .

 (a) Schedule
5.12(a) sets forth a true, correct and complete list of, and the Company has made available to SPAC true, correct and complete copies
of, each Contract to which any Target Company is a party or by which any Target Company, or any of its properties or assets are bound
or affected (each Contract required to be set forth on Schedule 5.12(a) , a “ Company Material Contract ”)
that:

 (i) contains
covenants that limit the ability of any Target Company (A) to compete in any line of business or with any Person or in any geographic
area or to sell, or provide any service or product or solicit any Person, including any non-competition covenants, employee and customer
non-solicit covenants, exclusivity restrictions, rights of first refusal or most-favored pricing clauses or (B) to purchase or acquire
an interest in any other Person;

 (ii) involves
any joint venture, profit-sharing, partnership, limited liability company or other similar agreement or arrangement relating to the formation,
creation, operation, management or control of any partnership or joint venture (other than the Company Operating Agreement);

 (iii) involves
any exchange traded, over the counter or other swap, cap, floor, collar, futures contract, forward contract, option or other derivative
financial instrument or Contract, based on any commodity, security, instrument, asset, rate or index of any kind or nature whatsoever,
whether tangible or intangible, including currencies, interest rates, foreign currency and indices;

 (iv) evidences
Indebtedness (whether incurred, assumed, guaranteed or secured by any asset) of any Target Company having an outstanding principal amount
in excess of $200,000;

 (v) involves
the acquisition or disposition, directly or indirectly (by merger or otherwise), of assets with an aggregate value in excess of $200,000
(other than in the ordinary course of business consistent with past practice) or shares or other equity interests of any Target Company
or another Person;

 (vi) relates
to any merger, consolidation or other business combination with any other Person or the acquisition or disposition of any other entity
or its business or material assets or the sale of any Target Company, its business or material assets;

 20

 (vii) by
its terms, individually or with all related Contracts, resulted, during the twelve (12)-month period prior to the date hereof, in aggregate
payments or receipts to or by the Target Companies under such Contract or Contracts of at least $100,000 or $200,000 in the aggregate;

 (viii) is
with any Top Customer or Top Supplier;

 (ix) obligates
the Target Companies to provide continuing indemnification or a guarantee of obligations of a third party after the date hereof in excess
of $200,000;

 (x) is
between any Target Company and any directors, officers or employees of a Target Company (other than at-will employment arrangements with
employees entered into in the ordinary course of business consistent with past practice), including all non-competition, severance and
indemnification agreements, or any Related Person;

 (xi) obligates
the Target Companies to make any capital commitment or expenditure in excess of $200,000 (including pursuant to any joint venture);

 (xii) relates
to a material settlement entered into within three (3) years prior to the date of this Agreement or under which any Target Company has
outstanding obligations (other than customary confidentiality obligations);

 (xiii) provides
another Person (other than another Target Company or any manager, director or officer of any Target Company) with a power of attorney;

 (xiv) relates
to the development, ownership, licensing or use of any material Intellectual Property by, to or from any Target Company, other than Off-the-Shelf
Software;

 (xv) that
will be required to be filed with the Registration Statement under applicable SEC requirements or would otherwise be required to be filed
by the Company as an exhibit for a Form S-1 pursuant to Items 601(b)(1), (2), (4), (9) or (10) of Regulation S-K under the Securities
Act as if the Company was the registrant; or

 (xvi) is
otherwise material to the Target Companies taken as a whole and not described in clauses (i) through (xv) above.

 (b) Except
as disclosed on Schedule 5.12(b) , with respect to each Company Material Contract: (i) such Company Material Contract is valid and
binding and enforceable in all material respects against the Target Company party thereto and, to the Knowledge of the Company, each other
party thereto, and is in full force and effect (except, in each case, as such enforcement may be limited by the Enforceability Exceptions),
(ii) the consummation of the transactions contemplated by this Agreement will not affect the validity or enforceability of any Company
Material Contract in any material respect, (iii) no Target Company is in breach or default in any material respect, and no event has occurred
that with the passage of time or giving of notice or both would constitute a material breach or default by any Target Company, or permit
termination or acceleration by the other party thereto, under such Company Material Contract; (iv) to the Knowledge of the Company,
no other party to such Company Material Contract is in breach or default in any material respect, and no event has occurred that with
the passage of time or giving of notice or both would constitute such a material breach or default by such other party, or permit termination
or acceleration by any Target Company, under such Company Material Contract; (v) no Target Company has received written notice of an intention
by any party to any such Company Material Contract that provides for a continuing obligation by any party thereto to terminate such Company
Material Contract or amend the terms thereof, other than modifications in the ordinary course of business that do not adversely affect
any Target Company in any material respect; and (vi) no Target Company has waived any material rights under any such Company Material
Contract.

 21

 5.13 Intellectual
Property .

 (a) Schedule
5.13(a)(i) sets forth: (i) all U.S. and foreign registered Patents, Trademarks, Copyrights and Internet Assets and applications owned
by a Target Company or otherwise used or held for use by a Target Company in which a Target Company is the owner, applicant or assignee
(“ Company Registered IP ”), specifying as to each item, as applicable: (A) the nature of the item, including
the title, (B) the owner of the item, (C) the jurisdictions in which the item is issued or registered or in which an application for issuance
or registration has been filed and (D) the issuance, registration or application numbers and dates and (ii) all material unregistered
Intellectual Property owned or purported to be owned by a Target Company. Schedule 5.13(a)(ii) sets forth all Intellectual Property
licenses, sublicenses and other agreements or permissions (“ Company IP Licenses ”) (other than “shrink
wrap,” “click wrap” and “off the shelf” software agreements and other agreements for Software commercially
available on reasonable terms to the public generally with license, maintenance, support and other fees of less than $10,000 per year
(collectively, “ Off-the-Shelf Software ”), which are not required to be listed, although such licenses are “Company
IP Licenses” as that term is used herein), under which a Target Company is a licensee or otherwise is authorized to use or practice
any Intellectual Property, and such Company IP Licenses describe all such Intellectual Property licensed under such Company IP Licenses.
Each Target Company owns, free and clear of all Liens (other than Permitted Liens), has valid and enforceable rights in, and has the unrestricted
right to use, sell, license, transfer or assign, all Intellectual Property currently used, licensed or held for use by such Target Company,
except for the Intellectual Property that is the subject of the Company IP Licenses. No item of Company Registered IP that consists of
a pending Patent application fails to identify all pertinent inventors, and for each Patent and Patent application in the Company Registered
IP, the Target Companies have obtained valid assignments of inventions from each inventor. Except as set forth on Schedule 5.13(a)(iii) ,
all Company Registered IP is owned exclusively by the applicable Target Company without obligation to pay royalties, licensing fees or
other fees, or otherwise account to any third party with respect to such Company Registered IP, and such Target Company has recorded assignments
of all Company Registered IP with any applicable Intellectual Property offices or Governmental Authorities.

 (b) Each
Target Company has a valid and enforceable license to use all Intellectual Property that is the subject of the Company IP Licenses applicable
to such Target Company. The Company IP Licenses include all of the licenses, sublicenses and other agreements or permissions necessary
to operate the Target Companies as presently conducted. Each Target Company has performed all obligations imposed on it in the Company
IP Licenses, has made all payments required to date, and such Target Company is not, nor, to the Knowledge of the Company, is any other
party thereto, in breach or default thereunder, nor has any event occurred that with notice or lapse of time or both would constitute
a default thereunder. The continued use by the Target Companies of the Intellectual Property that is the subject of the Company IP Licenses
in the same manner that it is currently being used is not restricted by any applicable license of any Target Company other than by any
applicable terms regarding term and renewal of such licenses. All registrations for Copyrights, Patents, Trademarks and Internet Assets
that are owned by or exclusively licensed to any Target Company are valid, in force and in good standing with all required fees and maintenance
and/or renewal fees having been paid with no Actions pending, and all current applications to register any Copyrights, Patents and Trademarks
are pending and in good standing, all without challenge of any kind other than office actions that may be issued by the applicable Intellectual
Property office or governmental agency in the ordinary course of filing and prosecuting such applications. No Target Company is party
to any Contract that requires a Target Company to assign to any Person all of its rights in any Intellectual Property developed by a Target
Company under such Contract.

 22

 (c) Schedule
5.13(c) sets forth all licenses, sublicenses and other agreements or permissions under which a Target Company is the licensor (each,
an “ Outbound IP License ”). Each Target Company has performed all obligations imposed on it in the Outbound IP
Licenses, and such Target Company is not, nor, to the Knowledge of the Company, is any other party thereto, in breach or default thereunder,
nor has any event occurred that with notice or lapse of time or both would constitute a default thereunder.

 (d) No
Action is pending or, to the Company’s Knowledge, threatened in writing against a Target Company that challenges the validity, enforceability,
ownership or right to use, sell, license or sublicense, or that otherwise relates to, any Intellectual Property currently owned by or
licensed to the Target Companies, nor, to the Knowledge of the Company, is there any reasonable basis for any such Action. No Target Company
has received any written notice or claim asserting or suggesting that any infringement, misappropriation, violation, dilution or unauthorized
use of the Intellectual Property of any other Person is or may be occurring or has or may have occurred, as a consequence of the business
activities of any Target Company, nor to the Knowledge of the Company is there a reasonable basis therefor. There are no Orders to which
any Target Company is a party or its otherwise bound that (i) restrict the rights of a Target Company to use, transfer, license or enforce
any Intellectual Property owned by a Target Company, (ii) restrict the conduct of the business of a Target Company in order to accommodate
a third Person’s Intellectual Property, or (iii) other than any applicable Outbound IP Licenses, grant any third Person any right
with respect to any Intellectual Property owned by a Target Company. To the Knowledge of the Company, no Target Company is currently infringing,
or has in the past infringed, misappropriated or violated any Intellectual Property of any other Person in any material respect in connection
with the ownership, use or license of any Intellectual Property owned or purported to be owned by a Target Company or, to the Knowledge
of the Company, otherwise in connection with the conduct of the respective businesses of the Target Companies. To the Company’s
Knowledge, no third party is currently, or in the past three (3) years has been, infringing upon, misappropriating or otherwise violating
any Intellectual Property owned, licensed by, licensed to, or otherwise used or held for use by any Target Company (“ Company
IP ”) in any material respect.

 (e) All
officers, directors, employees and independent contractors of a Target Company (and each of their respective Affiliates) have assigned
to the Target Companies all Intellectual Property arising from the services performed for a Target Company by such Persons and, where
applicable, all such assignments of Company Registered IP have been recorded. No current or former officers, employees or independent
contractors of a Target Company have claimed any ownership interest in any Intellectual Property owned by a Target Company. To the Knowledge
of the Company, there has been no violation of a Target Company’s policies or practices related to protection of Company IP or any
confidentiality or nondisclosure Contract relating to the Intellectual Property owned by a Target Company. The Company has made available
to SPAC true and complete copies of all written Contracts referenced in subsections under which employees and independent contractors
assigned their Intellectual Property to a Target Company. To the Company’s Knowledge, none of the employees of any Target Company
is obligated under any Contract, or subject to any Order, that would materially interfere with the use of such employee’s best efforts
to promote the interests of the Target Companies, or that would materially conflict with the business of any Target Company as presently
conducted or contemplated to be conducted. Each Target Company has taken reasonable security measures in order to protect the secrecy,
confidentiality and value of the material Company IP.

 (f) To
the Knowledge of the Company, no Person has obtained unauthorized access to third party information and data (including personally identifiable
information) in the possession of a Target Company, nor has there been any other material compromise of the security, confidentiality
or integrity of such information or data, and no written or, to the Knowledge of the Company, oral complaint relating to an improper use
or disclosure of, or a breach in the security of, any such information or data has been received by a Target Company. Each Target Company
has complied in all material respects with all applicable Laws and Contract requirements relating to privacy, personal data protection,
and the collection, processing and use of personal information and its own privacy policies and guidelines. The operation of the business
of the Target Companies has not and does not violate any right to privacy or publicity of any third person, or constitute unfair competition
or trade practices under applicable Law.

 23

 (g) The
consummation of any of the transactions contemplated by this Agreement will not result in the material breach, modification, cancellation,
termination, suspension of or acceleration of any payments with respect to, or release of source code because of (i) any Contract providing
for the license or other use of Intellectual Property owned by a Target Company, or (ii) any Company IP License. Following the Closing,
the Company shall be permitted to exercise, directly or indirectly through its Subsidiaries, all of the Target Companies’ rights
under such Contracts or Company IP Licenses to the same extent that the Target Companies would have been able to exercise had the transactions
contemplated by this Agreement not occurred, without the payment of any additional amounts or consideration other than ongoing fees, royalties
or payments which the Target Companies would otherwise be required to pay in the absence of such transaction.

 5.14 Taxes
and Returns .

 (a) Each
Target Company has or will have timely filed, or caused to be timely filed, all material Tax Returns required to be filed by it (taking
into account all available extensions), which Tax Returns are true, accurate, correct and complete in all material respects, and has paid,
collected or withheld, or caused to be paid, collected or withheld, all material Taxes required to be paid, collected or withheld, other
than such Taxes for which adequate reserves in the Company Financials have been established. Each Target Company has complied in all material
respects with all applicable Laws relating to Tax.

 (b) There
is no Action currently pending or, to the Knowledge of the Company, threatened in writing against a Target Company by a Governmental Authority
in a jurisdiction where the Target Company does not file Tax Returns that it is subject to taxation by that jurisdiction.

 (c) No
Target Company is being audited by any Tax authority or has been notified in writing by any Tax authority that any such audit is contemplated
or pending. There are no claims, assessments, audits, examinations, investigations or other Actions pending against a Target Company in
respect of any Tax, and no Target Company has been notified in writing of any proposed Tax claims or assessments against it (other than,
in each case, claims or assessments for which adequate reserves in the Company Financials have been established).

 (d) There
are no Liens with respect to any Taxes upon any Target Company’s assets, other than Permitted Liens.

 (e) No
Target Company has any outstanding waivers or extensions of any applicable statute of limitations to assess any amount of material Taxes.
There are no outstanding requests by a Target Company for any extension of time within which to file any Tax Return or within which to
pay any Taxes shown to be due on any Tax Return.

 (f) No
Target Company has made any change in accounting method (except as required by a change in Law) or entered into any closing agreement
with any taxing authority affecting or otherwise settled or compromised any material Tax Liability or refund.

 (g) No
Target Company has participated in, or sold, distributed or otherwise promoted, any “reportable transaction,” as defined in
U.S. Treasury Regulation section 1.6011-4.

 24

 (h) No
Target Company has any Liability or potential Liability for the Taxes of another Person (other than another Target Company) that are not
adequately reflected in the Company Financials (i) under any applicable Tax Law, (ii) as a transferee or successor, or (iii) by contract,
indemnity or otherwise (excluding commercial agreements entered into in the ordinary course of business the primary purpose of which is
not the sharing of Taxes). No Target Company is a party to or bound by any Tax indemnity agreement, Tax sharing agreement or Tax allocation
agreement or similar agreement, arrangement or practice (excluding commercial agreements entered into in the ordinary course of business
the primary purpose of which is not the sharing of Taxes) with respect to Taxes (including advance pricing agreement, closing agreement
or other agreement relating to Taxes with any Governmental Authority) that will be binding on any Target Company with respect to any period
following the Closing Date.

 (i) No
Target Company has requested, or is it the subject of or bound by any private letter ruling, technical advice memorandum, closing agreement
or similar ruling, memorandum or agreement with any Governmental Authority with respect to any Taxes, nor is any such request outstanding.

 (j) At
all times since each Target Company’s date of formation, each such Target Company has been classified as either a disregarded entity
or a partnership (in each case, for U.S. federal income Tax purposes or, where applicable, state and/or local income Tax purposes). No
such Target Company has made an election to be treated as an association taxable as a corporation for U.S. federal income Tax purposes
or, where applicable, state and/or local income Tax purposes.

 (k) To
the Knowledge of the Company, there are no facts or circumstances that would reasonably be expected to prevent the Mergers from qualifying
as an exchange described in Section 351 of the Code.

 5.15 Real
Property . Schedule 5.15 contains a complete and accurate list of all premises currently leased or subleased or otherwise used
or occupied by a Target Company for the operation of the business of a Target Company, and of all current leases and lease guarantees,
including all amendments, terminations and modifications thereof or waivers thereto (collectively, the “ Company Real Property
Leases ”), as well as the current annual rent and term under each Company Real Property Lease. The Company has provided to
SPAC a true and complete copy of each of the Company Real Property Leases. The Company Real Property Leases are valid, binding and enforceable
in accordance with their terms and are in full force and effect, subject to the Enforceability Exceptions. No event has occurred which
(whether with or without notice, lapse of time or both or the happening or occurrence of any other event) would constitute a default on
the part of a Target Company or, to the Knowledge of the Company, any other party under any of the Company Real Property Leases, and no
Target Company has received notice of any such condition. No Target Company owns or has ever owned any real property or any interest in
real property (other than the leasehold interests in the Company Real Property Leases).

 5.16 Personal
Property . Each item of Personal Property which is currently owned, used or leased by a Target Company with a book value or fair market
value of greater than Fifty Thousand Dollars ($50,000) is set forth on Schedule 5.16 , along with, to the extent applicable, a list
of lease agreements, lease guarantees, security agreements and other agreements related thereto, including all amendments, terminations
and modifications thereof or waivers thereto (“ Company Personal Property Leases ”). Except as set forth on Schedule
5.16 , all such items of Personal Property are in good operating condition and repair (reasonable wear and tear excepted consistent
with the age of such items) in all material respects, and are suitable for their intended use in the business of the Target Companies.
The operation of each Target Company’s business as it is now conducted or presently proposed to be conducted is not dependent upon
the right to use the Personal Property of Persons other than a Target Company, except for such Personal Property that is owned, leased
or licensed by or otherwise contracted to a Target Company. The Company has provided to SPAC a true and complete copy of each of the Company
Personal Property Leases. The Company Personal Property Leases are valid, binding and enforceable in accordance with their terms and are
in full force and effect. To the Knowledge of the Company, no event has occurred which (whether with or without notice, lapse of time
or both or the happening or occurrence of any other event) would constitute a default on the part of a Target Company or any other party
under any of the Company Personal Property Leases, and no Target Company has received notice of any such condition.

 25

 5.17 Title
to and Sufficiency of Assets . Each Target Company has good and marketable title to, or a valid leasehold interest in or right to use,
all of its assets, free and clear of all Liens other than (a) Permitted Liens, (b) the rights of lessors under leasehold interests, (c)
Liens specifically identified on the most recent balance sheet included in the Company Financials and (d) Liens set forth on Schedule
5.17 . The assets (including Intellectual Property rights and contractual rights) of the Target Companies constitute all of the material
assets, rights and properties that are currently used in the operation of the businesses of the Target Companies as it is now conducted
or that are used or held by the Target Companies for use in the operation of the businesses of the Target Companies, and taken together,
are adequate and sufficient for the operation of the businesses of the Target Companies as currently conducted.

 5.18 Employee
Matters

 (a) Except
as set forth on Schedule 5.18(a) , no Target Company is a party to any collective bargaining agreement or other Contract covering
any group of employees, labor organization or other representative of any of the employees of any Target Company, and the Company has
no Knowledge of any activities or proceedings of any labor union or other party to organize or represent such employees. There has not
occurred or, to the Knowledge of the Company, been threatened any strike, slow-down, picketing, work-stoppage, or other similar labor
activity with respect to any such employees. Schedule 5.18(a) sets forth all unresolved labor controversies (including unresolved
employee, consultant or independent contractor claims, grievances and/or disputes, whether raised internally with the Company or through
a representative, including any harassment, age or other discrimination, or retaliation claims, wage and hour claims, and any other claims
arising under local, state or federal labor and employment laws), if any, that are pending or, to the Knowledge of the Company, threatened
between any Target Company and Persons employed by or providing services as independent contractors to a Target Company. No current officer
or employee of a Target Company has provided any Target Company written or, to the Knowledge of the Company, oral notice of his or her
plan to terminate his or her employment with any Target Company.

 (b) Except
as set forth on Schedule 5.18(b) , each Target Company (i) is and for the last three (3) years has been in compliance in all material
respects with all applicable Laws respecting employment and employment practices, terms and conditions of employment, legally-required
trainings and notices, health and safety and wages and hours, and other Laws relating to discrimination, harassment, retaliation, disability,
labor relations, hours of work, payment of wages and overtime wages, pay equity, immigration, workers compensation, working conditions,
employee scheduling, occupational safety and health, family and medical leave, and employee terminations, and has not received written
notice that there is any pending Action involving unfair labor practices against a Target Company, (ii) is not liable for any material
past due arrears of wages or any material penalty for failure to comply with any of the foregoing, and (iii) is not liable for any
material payment to any Governmental Authority with respect to unemployment compensation benefits, social security or other benefits or
obligations for employees, independent contractors or consultants (other than routine payments to be made in the ordinary course of business
and consistent with past practice). There are no Actions pending or, to the Knowledge of the Company, threatened in writing against a
Target Company brought by or on behalf of any applicant for employment, any current or former employee, any Person alleging to be a current
or former employee, or any Governmental Authority, relating to any such Law or regulation, or alleging breach of any express or implied
contract of employment, wrongful termination of employment, or alleging any other discriminatory, wrongful or tortious conduct in connection
with the employment relationship.

 26

 (c) Schedule
5.18(c) hereto sets forth a complete and accurate list as of the date hereof of all employees of the Target Companies showing for
each as of such date (i) the employee’s name, job title or description, employer, location, salary level (including any bonus, commission,
deferred compensation or other remuneration payable (other than any such arrangements under which payments are at the discretion of the
Target Companies)), (ii) any bonus, commission or other remuneration other than salary paid during the fiscal year ending December 31,
2025, and (iii) any wages, salary, bonus, commission or other compensation due and owing to each employee during or for the fiscal year
ended December 31, 2025. Except as set forth on Schedule 5.18(c) , (A) no employee is a party to a written employment Contract with
a Target Company and each is employed “at will”, and (B) the Target Companies have paid in full to all their employees all
wages, salaries, commission, bonuses and other compensation due to their employees, including overtime compensation, and no Target Company
has any obligation or Liability (whether or not contingent) with respect to severance payments to any such employees under the terms of
any written agreement, or commitment or any applicable Law, custom, trade or practice. Except as set forth on Schedule 5.18(c) ,
each Target Company employee has entered into the Company’s standard form of employee non-disclosure, inventions and restrictive
covenants agreement with a Target Company (whether pursuant to a separate agreement or incorporated as part of such employee’s overall
employment agreement), a copy of which has been made available to SPAC by the Company.

 (d) Schedule
5.18(d) contains a list of all independent contractors (including consultants) currently engaged by any Target Company, along with
the position, the entity engaging such Person, date of retention and rate of remuneration, most recent increase (or decrease) in remuneration
and amount thereof, for each such Person. Except as set forth on Schedule 5.18(d) , all of such independent contractors are a party
to a written Contract with a Target Company. Except as set forth on Schedule 5.18(d) , each such independent contractor has entered
into customary covenants regarding confidentiality, non-competition and assignment of inventions and copyrights in such Person’s
agreement with a Target Company, a copy of which has been provided to SPAC by the Company. For the purposes of applicable Law, including
the Code, all independent contractors who are currently, or within the last three (3) years have been, engaged by a Target Company are
bona fide independent contractors and not employees of a Target Company. Each independent contractor is terminable on fewer than thirty
(30) days’ notice, without any obligation of any Target Company to pay severance or a termination fee.

 (e) To
the Knowledge of the Company, since January 1, 2025, the Company has investigated all workplace harassment (including sexual harassment),
discrimination, retaliation, and workplace violence written claims, if any, related to current and/or former employees of the Company
or third parties who interacted with current and/or former employees of the Company. Wit…

EX-10.1 · FORM OF SELLER SUPPORT AGREEMENT

EX-10.1
 3
 ea029430701ex10-1.htm
 FORM OF SELLER SUPPORT AGREEMENT

 Exhibit 10.1

 FORM OF SELLER SUPPORT AGREEMENT

 This Seller Support Agreement
(this “ Agreement ”) is made as of June ____, 2026 by and among (i) Copley Acquisition Corp , a Cayman Islands
exempted company incorporated with limited liability (together with its successors, including after the Conversion (as defined below),
the “ SPAC ”), (ii) Ignite Proteomics, LLC , a Delaware limited liability company (the “ Company ”),
and (iii) the undersigned holders of membership interests and/or interests convertible into membership interests (collectively, the “ Holders ”
and each, a “ Holder ”) of the Company. Any capitalized term used but not defined in this Agreement will have
the meaning ascribed to such term in the Business Combination Agreement.

 WHEREAS , on or about
the date hereof, (i) the SPAC, (ii) Ignite Proteomics Holdings, Inc., a Delaware corporation (“ Pubco ”), (iii)
 Ignite Merger Sub I Inc. , a Delaware corporation and a wholly-owned subsidiary of Pubco (“ SPAC Merger Sub ”),
(iv) Ignite Merger Sub II LLC , a Delaware limited liability company and a wholly-owned subsidiary of Pubco (“ Company
Merger Sub ”), (v) the Company, (vi) the SPAC Representative (as therein defined), and (vii) the Seller Representative (as
therein defined), have entered into that certain Business Combination Agreement (as amended from time to time in accordance with the terms
thereof, the “ Business Combination Agreement ”), pursuant to which, (a) prior to the closing of the transactions
contemplated by the Business Combination Agreement (the “ Closing ”), the SPAC shall transfer by way of continuation
out of the Cayman Islands and into the State of Delaware so as to convert into and become a Delaware corporation pursuant to the Cayman
Islands Companies Act (as Revised) (the “ Act ”) and the applicable provisions of the Delaware General Corporation
Law (“ DGCL ”) (the “ Conversion ”), and, at the Closing, (b) SPAC Merger Sub will merge
with and into the SPAC, with the SPAC continuing as the surviving entity (the “ SPAC Merger ”), with the security
holders of the SPAC receiving substantially equivalent security of Pubco, and (c) Company Merger Sub will merge with and into the Company,
with the Company continuing as the surviving entity (the “ Company Merger ”), with the security holders of the
Company receiving shares of Pubco Common Stock, all upon the terms and subject to the conditions set forth in the Business Combination
Agreement and in accordance with the applicable provisions of the DGCL and the Act; and

 WHEREAS , as a condition
to the willingness of the SPAC to enter into the Business Combination Agreement, and as an inducement and in consideration therefor, and
in view of the valuable consideration to be received by each Holder thereunder, and the expenses and efforts to be undertaken by the SPAC
and the Company to consummate the Business Combination Agreement, the Ancillary Documents, the Company Merger and the other transactions
contemplated by any such documents (collectively, the “ Transactions ”), the SPAC, the Company and such Holder
desire to enter into this Agreement in order for such Holder to provide certain assurances to the SPAC regarding the manner in which such
Holder is bound hereunder to vote any membership interest of the Company or other equity interests of the Company which such Holder beneficially
owns, holds or otherwise has voting power (the “ Membership Interests ”) during the period from and including
the date hereof through and including the date on which this Agreement is terminated in accordance with its terms (the “ Voting
Period ”) with respect to the Business Combination Agreement, the Company Merger, the Ancillary Documents and the Transactions.

 NOW, THEREFORE , in
consideration of the premises set forth above, which are incorporated in this Agreement as if fully set forth below, and intending to
be legally bound hereby, the parties hereby agree as follows:

 1. Covenant to Vote in
Favor of Transactions and Other Actions in Connection with the Transactions . Each Holder agrees, with respect to all of the Membership
Interests:

 (a) during
the Voting Period, at each meeting of the members of the Company (the “ Company Members ”) or any class or series
thereof, and in each written consent or resolutions of any of the Company Members in which such Holder is entitled to vote or consent
as a member of the Company, such Holder hereby unconditionally and irrevocably agrees to be present for such meeting or otherwise be counted
as present thereat for the purpose of establishing a quorum and vote (in person or by proxy), or consent to any action by written consent
or resolution, in accordance with the applicable provisions of the Company’s Operating Agreement dated May 29, 2024, and with respect
to, as applicable, the Membership Interests (i) in favor of, and adopt, the Company Merger, the Business Combination Agreement, the Ancillary
Documents, any amendments to the Company’s Organizational Documents (including the Company Operating Agreement), and all of the
other Transactions (and any actions required in furtherance thereof), (ii) in favor of the other matters set forth in the Business Combination
Agreement, and (iii) to vote the Membership Interests in opposition to: (A) any Acquisition Proposal or Alternative Transaction and any
and all other proposals (x) for the acquisition of the Company, (y) that could reasonably be expected to delay or impair the ability of
the Company to consummate the Company Merger, the Business Combination Agreement or any of the Transactions, or (z) which are in competition
with or materially inconsistent with the Business Combination Agreement or the Ancillary Documents; (B) other than as contemplated by
the Business Combination Agreement or the Ancillary Documents, any material change in (x) the present capitalization of the Company or
any amendment of the Company’s Organizational Documents (including the Company Operating Agreement) or (y) the Company’s limited
liability company structure or business; or (C) any other action or proposal involving any Target Company that is intended, or would reasonably
be expected, to prevent, impede, interfere with, delay, postpone or adversely affect in any material respect the Transactions or would
reasonably be expected to result in any of the conditions to the Closing under the Business Combination Agreement not being fulfilled;

 (b) to
promptly execute and deliver all related documentation and take such other action in support of the Company Merger, the Business Combination
Agreement, any Ancillary Documents and any of the Transactions as shall reasonably be requested by Pubco, the Company or the SPAC in order
to carry out the terms and provisions of this Section 1 , including, without limitation, (i) execution and delivery to the Company
of a Letter of Transmittal and the Transmittal Documents, (ii) if applicable, delivery of such Holder’s Company Certificate (or
a Lost Certificate Affidavit in lieu of the Company Certificate), duly endorsed for transfer, to Pubco and any similar or related documents
and such other documents as may be reasonably requested by Pubco or the SPAC or the Exchange Agent, (iii) any actions by written consent
of the Company Members presented to such Holder, and (iv) any applicable Ancillary Documents (including, without limitation, a Lock-Up
Agreement and a Non-Competition and Non-Solicitation Agreement), customary instruments of conveyance and transfer, and any consent, waiver,
governmental filing, and any similar or related documents;

 (c) not
to deposit, and to cause their Affiliates not to deposit, except as provided in this Agreement, any Membership Interests owned by such
Holder or his/her/its Affiliates in a voting trust or subject any Membership Interests to any arrangement or agreement with respect to
the voting of such Membership Interests, unless specifically requested to do so by the Company and the SPAC in connection with the Business
Combination Agreement, the Ancillary Documents or the Transactions;

 (d) except
as contemplated by the Business Combination Agreement or the Ancillary Documents, not make, or in any manner participate in, directly
or indirectly, a “solicitation” of “proxies” or consents (as such terms are used in the rules of the SEC) or powers
of attorney or similar rights to vote, or seek to advise or influence any Person with respect to the voting of, any Membership Interests
in connection with any vote or other action with respect to the Transactions, other than to recommend that the members of the Company
vote in favor of adoption of the Business Combination Agreement and the Transactions and any other proposal the approval of which is a
condition to the obligations of the parties under the Business Combination Agreement (and any actions required in furtherance thereof
and otherwise as expressly provided by Section 1 of this Agreement);

 2

 (e) to
refrain from exercising any dissenters’ rights or rights of appraisal under applicable Law at any time with respect to the Company
Merger, the Business Combination Agreement, the Ancillary Documents and any of the Transactions, including pursuant to the DGCL.

 2.
 Grant of Proxy . Each Holder, with respect to all of such Holder’s Membership Interests, hereby irrevocably grants to, and
appoints, the SPAC and any designee of the SPAC (determined in SPAC’s sole discretion) as such Holder’s attorney-in-fact and
proxy, with full power of substitution and resubstitution, for and in such Holder’s name, to vote, or cause to be voted (including
by proxy or written consent, if applicable) any Membership Interests owned (whether beneficially or of record) by such Holder as of the
date hereof and as of immediately prior to the Effective Time, with respect to any vote related to approval of the Business Combination
Agreement and the Transactions. The proxy granted by such Holder pursuant to this Section 2 is irrevocable and is granted in consideration
of the SPAC entering into this Agreement and the Business Combination Agreement and incurring certain related fees and expenses. Each
Holder hereby affirms that such irrevocable proxy is coupled with an interest by reason of the Business Combination Agreement and, except
upon the termination of this Agreement in accordance with Section 6(a) , is intended to be irrevocable. Each Holder agrees, until
this Agreement is terminated in accordance with Section 6(a) , to vote its Membership Interests in accordance with Section 1
above.

 3. O ther
Covenants .

 (a) No
Transfers . Each Holder agrees that during the Voting Period it shall not, and shall cause its Affiliates not to, without the SPAC’s
prior written consent, (A) offer for sale, sell (including short sales), transfer, tender, pledge, encumber, assign or otherwise dispose
of (including by gift) (collectively, a “ Transfer ”), (B) enter into any contract, option, derivative, hedging
or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or consent to, a Transfer
of, any or all of the Membership Interests; (C) grant any proxies or powers of attorney with respect to any or all of the Membership Interests;
(D) permit to exist any lien of any nature whatsoever (other than those imposed by this Agreement, applicable securities Laws or the Company’s
Organizational Documents (including the Company Operating Agreement), as in effect on the date hereof) with respect to any or all of the
Membership Interests; or (E) take any action that would have the effect of preventing, impeding, interfering with or adversely affecting
such Holder’s ability to perform its obligations under this Agreement. The Company hereby agrees that it shall not permit any Transfer
of the Membership Interests in violation of this Agreement. Each Holder agrees with, and covenants to, the SPAC that such Holder shall
not request that the Company register the Transfer (book-entry or otherwise) of any certificate or uncertificated interest representing
any Membership Interests during the term of this Agreement without the prior written consent of the SPAC, and the Company hereby agrees
that it shall not effect any such Transfer.

 (b) Changes
to Membership Interests . In the event of an equity distribution, or any change in the equity interests of the Company by reason of
any equity distribution, equity split, recapitalization, combination, conversion, exchange of equity interests or the like, the term “Membership
Interests” shall be deemed to refer to and include the Membership Interests as well as all such equity distributions and any securities
into which or for which any or all of the Membership Interests may be changed or exchanged or which are received in such transaction.
Each Holder agrees during the Voting Period to notify the SPAC and the Company promptly in writing of the number and type of any changes
to Holder’s ownership of or voting rights with respect to the Membership Interests, upon Holder’s acquisition or commitment
to acquire any additional Membership Interests or upon any other changes involving Holder relating to the equity interests or securities
convertible or exercisable for equity interests of the Company.

 3

 (c) Compliance
with Business Combination Agreement . Each Holder agrees during the Voting Period not to take or agree or commit to take any action
that would make any representation and warranty of such Holder contained in this Agreement inaccurate in any material respect. Each Holder
further agrees that it shall use its commercially reasonable efforts to cooperate with the SPAC to effect the Company Merger, all other
Transactions, the Business Combination Agreement, the Ancillary Documents and the provisions of this Agreement. During the Voting Period,
each Holder shall not authorize or permit any of its Representatives to, directly or indirectly, cause the Company to, take any action
that the Company is prohibited from taking pursuant to Section 6.2 of the Business Combination Agreement (unless the SPAC shall
have consented thereto).

 (d) Registration
Statement . During the Voting Period, each Holder agrees to provide to Pubco, the SPAC, the Company and their respective Representatives
any information regarding such Holder or the Membership Interests that is reasonably requested by Pubco, the SPAC, Company or their respective
Representatives for inclusion in the Registration Statement.

 (e) Publicity .
Except for disclosure required by the SEC, Nasdaq or NYSE, which disclosure is hereby expressly authorized, Holder shall not issue any
press release or otherwise make any public statements with respect to the Transactions or the transactions contemplated herein without
the prior written approval of the Company and the SPAC. Each Holder hereby authorizes the Company and the SPAC to publish and disclose
in any announcement or disclosure required by the SEC, NYSE or the Registration Statement (including all documents and schedules filed
with the SEC in connection with the foregoing), such Holder’s identity and ownership of the Membership Interests and the nature
of such Holder’s commitments and agreements under this Agreement, the Business Combination Agreement and any other Ancillary Documents.

 4. Representations
and Warranties of Holders . Each Holder hereby represents and warrants to the SPAC and the Company as follows:

 (a) Binding
Agreement . Such Holder (i) if a natural person, is of legal age to execute this Agreement and is legally competent to do so and (ii)
if not a natural person, is (A) a corporation, limited liability company, company or partnership duly organized and validly existing under
the laws of the jurisdiction of its organization and (B) has all necessary power and authority to execute and deliver this Agreement,
to perform its obligations hereunder and to consummate the transactions contemplated hereby. If such Holder is not a natural person, the
execution and delivery of this Agreement, the performance of its obligations hereunder and the consummation of the transactions contemplated
hereby by such Holder has been duly authorized by all necessary corporate, limited liability or partnership action on the part of such
Holder, as applicable. This Agreement, assuming due authorization, execution and delivery hereof by the other parties hereto, constitutes
a legal, valid and binding obligation of such Holder, enforceable against such Holder in accordance with its terms (except as such enforceability
may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general applicability
relating to or affecting creditor’s rights, and to general equitable principles). Such Holder understands and acknowledges that
the SPAC is entering into the Business Combination Agreement in reliance upon the execution and delivery of this Agreement by such Holder.

 (b) Ownership
of Membership Interests . As of the date hereof, such Holder has beneficial ownership over the Membership Interests set forth under
such Holder’s name on the signature page hereto, is the lawful owner of such Membership Interests, has the sole power to vote or
cause to be voted such Membership Interests (to the extent the Membership Interests have associated voting rights), and has good and valid
title to such Membership Interests, free and clear of any and all pledges, mortgages, encumbrances, charges, proxies, voting agreements,
liens, adverse claims, options, security interests and demands of any nature or kind whatsoever, other than those imposed by this Agreement,
applicable securities Laws or the Company’s Organizational Documents (including the Company Operating Agreement), as in effect on
the date hereof. There are no claims for finder’s fees or brokerage commission or other like payments in connection with this Agreement
or the transactions contemplated hereby payable by such Holder pursuant to arrangements made by such Holder. Except for the Membership
Interests of the Company set forth under such Holder’s name on the signature page hereto, as of the date of this Agreement, such
Holder is not a beneficial owner or record holder of any: (i) equity securities of the Company, (ii) securities of the Company having
the right to vote on any matters on which the holders of equity securities of the Company may vote or which are convertible into or exchangeable
for, at any time, equity securities of the Company or (iii) options, warrants or other rights to acquire from the Company any equity securities
or securities convertible into or exchangeable for equity securities of the Company.

 4

 (c) No
Conflicts . No filing with, or notification to, any Governmental Authority, and no consent, approval, authorization or permit of any
other person is necessary for the execution of this Agreement by such Holder, the performance of its obligations hereunder or the consummation
by it of the transactions contemplated hereby. None of the execution and delivery of this Agreement by such Holder, the performance of
its obligations hereunder or the consummation by it of the transactions contemplated hereby shall (i) conflict with or result in any breach
of the certificate of incorporation, bylaws or other comparable organizational documents of such Holder, if applicable, (ii) result in,
or give rise to, a violation or breach of or a default under any of the terms of any Contract or obligation to which such Holder is a
party or by which such Holder or any of the Membership Interests or its other assets may be bound, or (iii) violate any applicable Law
or Order, except for any of the foregoing in clauses (i) through (iii) as would not reasonably be expected to impair such Holder’s
ability to perform its obligations under this Agreement in any material respect.

 (d) No Inconsistent
Agreements . Holder hereby covenants and agrees that, except for this Agreement, Holder (i) has not entered into, nor will enter into
at any time while this Agreement remains in effect, any voting agreement or voting trust with respect to the Membership Interests, (ii)
has not granted, nor will grant at any time while this Agreement remains in effect, a proxy, a consent or power of attorney with respect
to the Membership Interests and (iii) has not entered into any agreement or knowingly taken any action (nor will enter into any agreement
or knowingly take any action) that would make any representation or warranty of Holder contained herein untrue or incorrect in any material
respect or have the effect of preventing Holder from performing any of its material obligations under this Agreement.

 5. Waiver
and Release of Claims . Holder covenants and agrees as follows:

 (a) Subject
to and conditioned upon the Closing, effective as of the Closing (and subject to the limitations set forth in paragraph (d) below), Holder,
on behalf of itself and its Affiliates and its and their respective successors, assigns, representatives, administrators, executors and
agents, and any other person or entity claiming by, through, or under any of the foregoing (each a “ Releasing Party ”
and, collectively, the “ Releasing Parties ,” provided, for the avoidance of doubt, that the SPAC, shall not be
deemed a Releasing Party hereunder), does hereby unconditionally and irrevocably release, waive and forever discharge Pubco, the SPAC,
the Company, and each of their past and present directors, officers, employees, agents, predecessors, successors, assigns, and Subsidiaries,
from any and all past or present claims, demands, damages, judgments, causes of action and liabilities of any nature whatsoever, whether
or not known, suspected or claimed, arising directly or indirectly from any act, omission, event or transaction occurring (or any circumstances
existing) at or prior to the Closing, in each case to the extent arising out of or relating to Holder’s capacity as a current or
former member of the Company or holder of any other equity securities of the Company (or securities convertible into equity securities
of the Company) (each a “ Claim ” and, collectively, the “ Claims ”).

 5

 (b) Holder
acknowledges that it may hereafter discover facts in addition to or different from those which it now knows or believes to be true with
respect to the subject matter of this Agreement, and that it may hereafter come to have a different understanding of the law that may
apply to potential claims which it is releasing hereunder, but it affirms that, except as is otherwise specifically provided herein, it
is its intention to fully, finally and forever settle and release any and all Claims. In furtherance of this intention, Holder acknowledges
that the releases contained herein shall be and remain in effect as full and complete general releases with respect to the specified subject
matter notwithstanding the discovery or existence of any such additional facts or different understandings of law.

 (c) Holder understands
that Holder has the right not to release existing Claims of which Holder is not aware, unless Holder voluntarily chooses to waive this
right. Having been so apprised, Holder elects to assume all risks for Claims that exist, existed or may hereafter exist in its favor,
known or unknown, suspected or unsuspected, arising out of or related to claims or other matters purported to be released pursuant to
this Section 5 , in each case, effective as of the Closing. Holder acknowledges and agrees that the foregoing waiver is an essential
and material term of the release provided pursuant to this Section 5 and that, without such waiver, the SPAC and the Company would
not have agreed to the terms of this Agreement.

 (d) Notwithstanding
the foregoing provisions of this Section 5 or anything to the contrary set forth herein, the Releasing Parties do not release or
discharge, and each Releasing Party expressly does not release or discharge: (i) any Claims that arise under or are based upon the terms
of the Business Combination Agreement, this Agreement, any of the Ancillary Documents, or any other document, certificate or Contract
executed or delivered in connection with the Business Combination Agreement, as each such agreement or instrument may be amended in accordance
with its terms and the terms set forth in (A) the Business Combination Agreement or (B) this Agreement or the other Ancillary Documents
(if and to the extent applicable), (ii) any rights with respect to the Membership Interests of the Company or the SPAC owned by such Releasing
Party, (iii) any Claims for indemnification, contribution, set-off, reimbursement or similar rights pursuant to any organizational document
of the Company or any indemnity or similar agreements by the Company with or for the benefit of a Releasing Party solely to the extent
(in each case) contemplated by Section 6.18 of the Business Combination Agreement, (iv) any Claims for compensation, reimbursement of
expenses or benefits payable to such Holder in his, her or its capacity as an officer, director, employee, consultant or contractor of
the Company or any of its Subsidiaries; or (v) any Claims for obligations pursuant to, or other rights set forth in, any employment or
similar agreement between Holder, on the one hand, and the Company or any Subsidiary of the Company, on the other hand, together with
any other agreements, documents, instruments or certificates contemplated by the foregoing, as well as any other employment related rights
that such Holder has by Contract or pursuant to applicable Law.

 6. Miscellaneous .

 (a) Termination .
Notwithstanding anything to the contrary contained herein, this Agreement shall automatically terminate, and none of the SPAC, the Company
or any Holder shall have any rights or obligations hereunder, upon the earliest to occur of (i) the mutual written consent of the SPAC
and the Company, (ii) the Effective Time (following the performance of the obligations of the parties hereunder required to be performed
at or prior to the Effective Time), and (iii) the date of termination of the Business Combination Agreement in accordance with its terms.
The termination of this Agreement shall not prevent any party hereunder from seeking any remedies (at law or in equity) against another
party hereto or relieve such party from liability for such party’s breach of any terms of this Agreement. Notwithstanding anything
to the contrary herein, the provisions of this Section 6 shall survive the termination of this Agreement.

 6

 (b) Binding
Effect; Assignment . This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of the parties
hereto and their respective permitted successors and assigns. This Agreement and all obligations of Holder are personal to Holder and
may not be assigned, transferred or delegated by operation of Law or otherwise without the prior written consent of the SPAC and the Company
(and after the Closing, Pubco), and any purported assignment, transfer or delegation without such consent shall be null and void; provided
that no such assignment shall relieve the assigning party of its obligations hereunder. Each of the Company and the SPAC may freely assign
any or all of its rights under this Agreement, in whole or in part, to any successor entity (whether by merger, consolidation, equity
sale, asset sale or otherwise) without obtaining the consent or approval of Holder.

 (c) Third
Parties . Nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions
contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person that is not a party
hereto or thereto or a successor or permitted assign of such a party.

 (d) Governing
Law; Jurisdiction . This Agreement and any dispute or controversy arising out of or relating to this Agreement shall be governed by
and construed in accordance with the Laws of the State of New York without regard to the conflict of laws principles thereof. All Actions
arising out of or relating to this Agreement shall be heard and determined exclusively in any state or federal court located in New York,
New York (or in any appellate court thereof) (the “ Specified Courts ”). Each party hereto hereby (a) submits
to the exclusive jurisdiction of any Specified Courts for the purpose of any Action arising out of or relating to this Agreement brought
by any party hereto and (b) irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action,
any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from
attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement
or the transactions contemplated hereby may not be enforced in or by any Specified Courts. Each party agrees that a final judgment in
any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law.
Each party irrevocably consents to the service of the summons and complaint and any other process in any other Action relating to the
transactions contemplated by this Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such
party at the applicable address set forth in Section 6(g) (and in the case of Holder, the address set forth on such Holder’s
signature page). Nothing in this Section 6(d) shall affect the right of any party to serve legal process in any other manner permitted
by applicable law.

 (e) WAIVER
OF JURY TRIAL . EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO
A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (ii) ACKNOWLEDGES THAT IT AND THE
OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION
6(e) .

 (f) Interpretation .
The titles and subtitles contained in this Agreement are solely for the purpose of reference, are not part of the agreement of the parties
and shall not in any way affect the meaning or interpretation of this Agreement. In this Agreement, unless the context otherwise requires:
(i) any pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns,
pronouns and verbs, including any defined terms, include the plural and vice versa; (ii) “including” (and with correlative
meaning “include”) means including without limiting the generality of any description preceding or succeeding such term and
shall be deemed in each case to be followed by the words “without limitation”; (iii) the words “herein,” “hereto,”
and “hereby” and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as
a whole and not to any particular section or other subdivision of this Agreement; (iv) the word “if” and other words of similar
import when used herein shall be deemed in each case to be followed by the phrase “and only if”; and (v) the term “or”
means “and/or”. The parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in
the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the
parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any
provision of this Agreement.

 7

 (g) Notices .
All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when
delivered (i) in person, (ii) by electronic means (including email), with affirmative confirmation of receipt, (iii) one Business Day
after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three (3) Business Days after being mailed,
if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable party at the following
addresses (or at such other address for a party as shall be specified by like notice):

 If to the SPAC, to:

 Copley Acquisition Corp.

 Suite 4005-4006, 40/F, One Exchange Square

 8 Connaught Place, Central, Hong Kong

 Attn: [***]

 Email: [***]

 with a copy (which will not constitute notice) to:

 Winston Taylor LLP

 800 Capitol St., Suite 2400

 Houston, Texas 77002

 Attn: [***]

 Telephone No.: [***]

 Email: [***]

 If to the Company, to:

 Ignite Proteomics, LLC

 [***]

 [***]

 Attn: [***]

 Telephone No.: [***]

 Email: [***]

 with a copy (which will not constitute notice) to:

 Meister Seelig & Schuster PLLC

 125 Park Avenue, 7 th Floor

 New York, New York 10017

 Attn: Louis Lombardo

 Telephone No.: [***]

 Email: [***]

 If to a Holder, to: the address set forth under such Holder’s name on the signature page hereto, with a copy (which will not constitute notice) to, if not the party sending the notice, each of the Company and the SPAC (and each of their copies for notices hereunder).

 (h) Amendments
and Waivers . Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally
or in a particular instance, and either retroactively or prospectively) only with the written consent of the SPAC, the Company and each
Holder. No failure or delay by a party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions
to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further
or continuing waiver of any such term, condition, or provision.

 8

 (i) Severability .
In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified
or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity,
legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity,
legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other
provision is invalid, illegal or incapable of being enforced, the parties will substitute for any invalid, illegal or unenforceable provision
a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid,
illegal or unenforceable provision.

 (j) Specific
Performance . Each Holder acknowledges that its obligations under this Agreement are unique, recognizes and affirms that in the event
of a breach of this Agreement by such Holder, money damages will be inadequate and the Company and the SPAC will not have an adequate
remedy at law, and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed
by such Holder in accordance with their specific terms or were otherwise breached. Accordingly, the Company and the SPAC shall be entitled
to seek an injunction or restraining order to prevent breaches of this Agreement by any such Holder and to enforce specifically the terms
and provisions hereof, without the requirement to post any bond or other security or to prove that money damages would be inadequate,
this being in addition to any other right or remedy to which such party may be entitled under this Agreement, at law or in equity.

 (k) Expenses .
Each party shall be responsible for its own fees and expenses (including the fees and expenses of investment bankers, accountants and
counsel) in connection with the entering into of this Agreement, the performance of its obligations hereunder and the consummation of
the transactions contemplated hereby; provided, that in the event of any Action arising out of or relating to this Agreement, the non-prevailing
party in any such Action will pay its own expenses and the reasonable documented out-of-pocket expenses, including reasonable attorneys’
fees and costs, reasonably incurred by the prevailing party.

 9

 (l) No
Partnership, Agency or Joint Venture . This Agreement is intended to create a contractual relationship among the Holders, the Company
and the SPAC, and is not intended to create, and does not create, any agency, partnership, joint venture or any like relationship among
the parties hereto or among any other Company Members entering into voting agreements with the Company or the SPAC. No Holder is affiliated
with any other holder of Membership Interests entering into a voting or support agreement with the Company or the SPAC in connection with
the Business Combination Agreement and Holder has acted independently regarding its decision to enter into this Agreement. Nothing contained
in this Agreement shall be deemed to vest in the Company or the SPAC any direct or indirect ownership or incidence of ownership of or
with respect to any Membership Interests.

 (m) Further
Assurances . From time to time, at another party’s request and without further consideration, each party shall execute and deliver
such additional documents and take all such further action as may be reasonably necessary or desirable to consummate the transactions
contemplated by this Agreement.

 (n) Entire
Agreement . This Agreement (together with the Business Combination Agreement to the extent referred to herein) constitutes the full
and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement
relating to the subject matter hereof existing between the parties is expressly canceled; provided , that, for the avoidance
of doubt, the foregoing shall not affect the rights and obligations of the parties under the Business Combination Agreement or any Ancillary
Document. Notwithstanding the foregoing, nothing in this Agreement shall limit any of the rights or remedies of the SPAC or any of the
obligations of any Holder under any other agreement between such Holder and the SPAC or any certificate or instrument executed by such
Holder in favor of the SPAC, and nothing in any other agreement, certificate or instrument shall limit any of the rights or remedies of
the SPAC or any of the obligations of such Holder under this Agreement.

 (o) Counterparts .
This Agreement may be executed and delivered (including by electronic signature or by email in portable document format) in two or more
counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original
but all of which taken together shall constitute one and the same agreement.

 [Remainder of Page Intentionally Left Blank;
Signature Page Follows]

 10

 IN WITNESS WHEREOF , the parties have executed
this Agreement as of the date first written above.

 The SPAC:

 COPLEY ACQUISITION CORP

 By:

 Name:

 Title:

 The Company :

 IGNITE PROTEOMICS, LLC

 By:

 Name:

 Title:

 [Signature Pages Continue]

 {Signature Page to Seller Support Agreement}

 Holder :

 By:

 Name:

 Total Membership Interests :

 Number and class of Units of the Company: ______________

 Address for Notice:

 Address:

 Telephone No.:

 Email:

 {Signature Page to Seller Support Agreement}

EX-10.2 · AMENDMENT TO LETTER AGREEMENT, DATED AS OF JUNE 10, 2026, BY AND AMONG COPLEY AC

EX-10.2
 4
 ea029430701ex10-2.htm
 AMENDMENT TO LETTER AGREEMENT, DATED AS OF JUNE 10, 2026, BY AND AMONG COPLEY ACQUISITION CORP., COPLEY ACQUISITION SPONSORS, LLC, IGNITE PROTEOMICS HOLDINGS, INC., IGNITE PROTEOMICS, LLC, AND THE OTHER PARTIES SIGNATORY THERETO

 Exhibit 10.2

 AMENDMENT TO LETTER AGREEMENT

 THIS AMENDMENT TO LETTER
AGREEMENT (this “ Amendment ”) is made and entered into as of [__], 2026, and shall be effective as of the
Closing (defined below), by and among (i) Copley Acquisition Corp , a Cayman Islands exempted company incorporated with limited
liability (“ Company ” or the “ SPAC ”), (ii) Copley Acquisition Sponsors, LLC ,
a Delaware limited liability company (the “ Sponsor ”), (iii) [ Ignite Holdings, Inc. ], a Delaware corporation
(“ Pubco ”), (iv) Ignite Proteomics, LLC , a Delaware limited liability company (the “ Target
Company ”), and (v) the undersigned individuals, each of whom is a member of the Company’s board of directors and/or
management team and who, along with the Sponsor and other transferees of the applicable Company securities, is referred to as an “ Insider ”
pursuant to the terms of the Letter Agreement (as defined below). Capitalized terms used but not otherwise defined herein shall have the
respective meanings assigned to such terms in the Original Letter Agreement (as defined below) (and if such term is not defined in the
Original Letter Agreement, then in the Business Combination Agreement (as defined below)).

 RECITALS

 WHEREAS , Company, the
Sponsor and the other undersigned Insiders are parties to that certain Letter Agreement, dated as of April 30, 2025 (the “ Original
Letter Agreement ” and, as amended by this Amendment, the “ Letter Agreement ”), pursuant to which
the Sponsor and the undersigned Insiders agreed, among other matters, to (i) waive their redemption rights with respect to their
Ordinary Shares that they may have in connection with the consummation of the proposed Business Combination, (ii) waive their rights
to liquidating distributions from the Trust Account with respect to their Founder Shares (although they will be entitled to liquidating
distributions from the trust account with respect to any Offering Shares), (iii) vote any Ordinary Shares owned by it, him or her
in favor of any proposed Business Combination for which the Company seeks approval, and (iv) certain transfer restrictions with respect
to the Founder Shares, Private Placement Warrants and Working Capital Warrants (and the Ordinary Shares underlying such Private Placement
Warrants and Working Capital Warrants);

 WHEREAS , on or about
the date hereof, the Company, Pubco, the Target Company, [ Ignite Merger Sub I Inc. ], a Delaware corporation (“ SPAC
Merger Sub ”) and [ Ignite Merger Sub II LLC ], a Delaware limited liability company and a wholly-owned subsidiary of
Pubco (“ Company Merger Sub ”), and the other parties thereto, entered into that certain Business Combination
Agreement (the “ Business Combination Agreement ”);

 WHEREAS , pursuant to
the Business Combination Agreement, subject to the terms and conditions thereof, among other matters, the SPAC shall continue out of the
Cayman Islands and into the State of Delaware so as to convert into and become a Delaware corporation pursuant to the Cayman Islands Companies
Act (as Revised) (the “ Act ”) and the applicable provisions of the Delaware General Corporation Law (the “ DGCL ”)
and, upon the consummation of the transactions contemplated by the Business Combination Agreement (the “ Closing ”):
(a) SPAC Merger Sub will merge with and into SPAC, with SPAC continuing as the surviving entity (the “ SPAC Merger ”)
and each issued and outstanding security of the SPAC immediately prior to the effective time of the SPAC Merger shall no longer be outstanding
and shall automatically be cancelled, in exchange for the issuance to the holder thereof of a substantially equivalent Pubco security;
(b) Company Merger Sub will merge with and into the Target Company, with the Target Company continuing as the surviving entity (the “ Company
Merger ” and together with the SPAC Merger, the “ Mergers ”) and each issued and outstanding security
of the Target Company immediately prior to the effective time of the Company Merger shall no longer be outstanding and shall automatically
be cancelled, in exchange for the issuance to the holder thereof of shares of common stock of Pubco; and (c) as a result of the Mergers,
the SPAC and the Target Company will become wholly-owned subsidiaries of Pubco and Pubco will become a publicly traded company, all in
accordance with the applicable provisions of the DGCL and the Act;

 WHEREAS , the parties
hereto desire to amend the Original Letter Agreement (i) to add Pubco and the Target Company as parties to the Letter Agreement, (ii)
to revise the terms thereof in order to reflect the transactions contemplated by the Business Combination Agreement, including without
limitation the issuance of shares of Pubco Common Stock and Pubco Warrants in exchange for the Company’s Ordinary Shares and Warrants,
respectively, and (iii) to amend the terms of the lock-up set forth in Section 5 of the Original Agreement; and

 WHEREAS , pursuant to
 Section 13 of the Original Letter Agreement, the Original Letter Agreement can be amended with the written consent of each Insider,
the Sponsor and Company.

 NOW, THEREFORE , in
consideration of the premises and the mutual promises herein made, and in consideration of the representations, warranties and covenants
herein contained, and intending to be legally bound hereby, the parties hereto agree as follows:

 1. Addition
of Pubco and the Target Company as Parties to the Letter Agreement . The parties hereby agree to add Pubco and the Target Company as
parties to the Letter Agreement. The parties further agree that, from and after the Closing, (i) all of the rights and obligations of
the Company under the Letter Agreement shall be, and hereby are, assigned and delegated to Pubco as if it were the original “Company”
party thereto, and (ii) all references to the Company under the Letter Agreement relating to periods from and after the Closing shall
instead be a reference to Pubco. By executing this Amendment, Pubco hereby agrees to be bound by and subject to all of the terms and conditions
of the Letter Agreement, as amended by this Amendment, from and after the Closing as if it were the original “Company” party
thereto.

 2. Amendments
to the Letter Agreement . The parties hereby agree to the following amendments to the Letter Agreement:

 (a) The
defined terms in this Amendment, including without limitation in the preamble and recitals hereto, and the definitions incorporated by
reference from the Business Combination Agreement, are hereby added to the Letter Agreement as if they were set forth therein.

 (b) The
parties hereby agree that (i) the terms “Offering Shares,” “Class A Ordinary Shares,” “Class B Ordinary
Shares,” “Ordinary Shares,” and “Founder Shares”, as used in the Letter Agreement shall include without
limitation any and all shares of Pubco Common Stock into which any such securities will convert in the Mergers, and (ii) the terms “Private
Placement Warrants” and “Working Capital Warrants” shall include without limitation any and all Pubco Private Warrants
into which such securities will convert in the Mergers. The parties further agree that from and after the Closing, any reference in the
Letter Agreement to the terms “Private Placement Warrants” and “Working Capital Warrants” will instead refer to
Pubco Private Warrants (and any warrants of Pubco or any successor entity issued in consideration of or in exchange for any of such warrants).

 (c) Effective
upon the Closing, Section 5(a) of the Original Letter Agreement is hereby deleted in its entirety and replaced with the following:

 “(a) any Founder
Shares or the Class A Ordinary Shares issuable upon conversion of the Founder Shares (the “ Founder Shares Lock-up ”)
until the earlier of (i) 90 days following the consummation of the Business Combination; or (ii) the date on which the Company completes
a liquidation, merger, share exchange, reorganization or other similar transaction after the initial Business Combination, that results
in all of the Company’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property (the
“ Founder Shares Lock-up Period ”); and”

 2

 3. Effectiveness .
Notwithstanding anything to the contrary contained herein, this Amendment shall become effective upon the Closing. In the event that the
Business Combination Agreement is terminated in accordance with its terms prior to the Closing, this Amendment and all rights and obligations
of the parties hereunder shall automatically terminate and be of no further force or effect.

 4. Miscellaneous .
Except as expressly provided in this Amendment, all of the terms and provisions in the Original Letter Agreement are and shall remain
in full force and effect, on the terms and subject to the conditions set forth therein. This Amendment does not constitute, directly or
by implication, an amendment or waiver of any provision of the Original Letter Agreement, or any other right, remedy, power or privilege
of any party thereto, except as expressly set forth herein. Any reference to the Letter Agreement in the Original Letter Agreement or
any other agreement, document, instrument or certificate entered into or issued in connection therewith shall hereinafter mean the Letter
Agreement, as amended by this Amendment (or as the Letter Agreement may be further amended or modified in accordance with the terms thereof
and hereof). The terms of this Amendment shall be governed by, enforced and construed and interpreted in a manner consistent with the
provisions of the Original Letter Agreement, including without limitation Section 13 thereof.

 {REMAINDER OF PAGE INTENTIONALLY LEFT BLANK;
SIGNATURE PAGES FOLLOW}

 3

 IN WITNESS WHEREOF ,
each party hereto has signed or has caused to be signed by its officer thereunto duly authorized this Amendment as of the date first above
written.

 Sincerely,

 COPLEY ACQUISITION SPONSORS, LLC

 By:

 Name:

 Title:

 COPLEY ACQUISITION CORP

 By:

 Name:

 Title:

 IGNITE HOLDINGS, INC.

 By:

 Name:

 Title:

 IGNITE PROTEOMICS, LLC

 By:

 Name:

 Title:

 {Signature Page to Amendment to Letter Agreement}

 Name:
 Francis Chi Yin Ng

 Name:
 Chibo Tang

 Name:
 Menghan “Henry” Zhang

 Name:
 Tok Li

 Name:
 Chun Kit Chu

 Name:
 Tsz Chiu Guan

 Name:
 Jean-Baptiste Djebbari

 Name:
 Ying Shirley Meng

 Name:
 Rebecca Fannin

 Name:
 Robert J. Whitsitt

 {Signature Page to Amendment to Letter Agreement}